<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <script type="text/javascript">var ncbi_startTime = new Date();</script>
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="diaclinneuro" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC3181622/" /><meta name="ncbi_app" content="pmc" />
        <!-- Logger end -->
        
        <title>Alcohol, nicotine, caffeine, and mental disorders</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181622/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Dialogues in Clinical Neuroscience" /><meta name="citation_title" content="Alcohol, nicotine, caffeine, and mental disorders" /><meta name="citation_authors" content="Marc-Antoine Crocq" /><meta name="citation_date" content="June 2003" /><meta name="citation_issue" content="2" /><meta name="citation_volume" content="5" /><meta name="citation_firstpage" content="175" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC3181622/?report=abstract" /><meta name="citation_pmid" content="22033899" /><meta name="DC.Title" content="Alcohol, nicotine, caffeine, and mental disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Les Laboratoires Servier" /><meta name="DC.Contributor" content="Marc-Antoine Crocq" /><meta name="DC.Date" content="2003 Jun" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Alcohol, nicotine, caffeine, and mental disorders" /><meta property="og:type" content="article" /><meta property="og:description" content="Alcohol, nicotine, and caffeine are the most widely consumed psychotropic drugs worldwide. They are largely consumed by normal individuals, but their use is even more frequent in psychiatric patients, Thus, patients with schizophrenia tend to abuse all ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181622/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript" src="/core/mathjax/2.6.1/MathJax.js?config=/corehtml/pmc/js/mathjax-config-classic.3.4.js"></script><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-diaclinneuro.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">
        div.pmc_para_cit li.highlight,
        div.pmc_para_cit li.highlight .one_line_source
        { background: #E0E0E0; }
        a.bibr.highlight { background: #E0E0E0; } 
      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC3181622/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC3181622/pdf/DialoguesClinNeurosci-5-175.pdf" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C0C85D004A13100000000047E0259.m_8" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>
    <body class="article">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo">
  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>
  <div class="NLMLogo">
    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>
    <br />
    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>
  </div>
</div>
    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option><option value="unigene">UniGene</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'pmc-search-autocomplete',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'yes'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/pmc/advanced/">Advanced</a>
                    </li><li>
                        <a href="/pmc/journals/">Journal list</a>
                    </li><li class="help">
                        <a target="_blank" href="/books/NBK3825/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <div class="container">
    <div id="maincontent" class="content eight_col col">
        <div class="navlink-box">
            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/1550/">Dialogues Clin Neurosci</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/200428/">v.5(2); 2003 Jun</a></li><li class="accid">PMC3181622</li></ul>
        </div>

        <!-- Journal banner -->
        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-diaclinneuro.gif" alt="Logo of diaclinneuro" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher's site" title="Link to Publisher's site" shape="default" coords="0,0,499,74" href="http://www.dialogues-cns.org/" target="pmc_ext" ref="reftype=publisher&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>
        
        <!--component id='MainPortlet' label='search-reference'/-->
        
        <!-- Book content -->
        <div class="">
            
        
            
            <div class="hide-overflow article lit-style content pmc-wm slang-en page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: ['h2'], headingExclude: ':hidden'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">Dialogues Clin Neurosci</span>. 2003 Jun; 5(2): 175–185. </span></div><div>  </div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC3181622</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/22033899">22033899</a></div></div></div></div><p class="whole_rythm mul-switcher">Language: <a href="#" class="lang-sw selected" lang="en">English</a> | <a href="#" class="lang-sw" lang="es">Spanish</a> | <a href="#" class="lang-sw" lang="fr">French</a></p><h1 class="content-title" lang="en">Alcohol, nicotine, caffeine, and mental disorders</h1><h1 class="content-trans-title" lang="es">Alcohol, nicotina, cafeina y trastornos mentales</h1><h1 class="content-trans-title" lang="fr">Alcool, nicotine, caf&#x000e9;ine et troubles mentaux</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Crocq%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22033899" class="affpopup" co-rid="_co_idm140379483751392" co-class="co-affbox">Marc-Antoine Crocq</a>, MD<sup>*</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140379483751392"><h3 class="no_margin">Marc-Antoine Crocq</h3><p>FORENAP, Institute for Research in Neuroscience and Neuropsychiatry, Rouffach, France</p><div>Find articles by <a href="/pubmed/?term=Crocq%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=22033899">Marc-Antoine Crocq</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140379486855840_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140379486855840_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140379486855840_ai" style="display:none"><div><span class="fm-affl">Marc-Antoine Crocq, </span><span class="fm-affl" lang="en" id="idm140379482850592"> FORENAP, Institute for Research in Neuroscience and Neuropsychiatry, Rouffach, France;</span></div><div id="COR1"><sup>*</sup> E-mail: <a href="mailto:dev@null" data-email="rf.hcaffuor-hc@qcorc.am" class="oemail">rf.hcaffuor-hc@qcorc.am</a></div></div><div class="fm-article-notes fm-panel half_rhythm"></div><div class="permissions fm-panel half_rhythm hide" id="idm140379486855840_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> : &#x000a9; 2003 LLS</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by-nc-nd/3.0/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by-nc-nd/3.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC3181622/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140379488217648" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140379488217648title">Abstract</h2><!--article-meta--><div><p id="__p1" class="p p-first-last">Alcohol, nicotine, and caffeine are the most widely consumed psychotropic drugs worldwide. They are largely consumed by normal individuals, but their use is even more frequent in psychiatric patients, Thus, patients with schizophrenia tend to abuse all three substances. The interrelationships between depression and alcohol are complex. These drugs can all create dependence, as understood in the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Alcohol abuse is clearly deleterious to the brain, provoking acute and chronic mental disorders, ranging from intoxication with impairment of cognition, to delirium tremens, halluosis, and dementia. In contrast, the main health consequences of nicotine, notably cancer and cardiovascular disases, lie outside the realm of psychiatry However, the mes of nicotine dependence and motivation to smoke or quit are of concern to psychiatrists.</p></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text"><em>alcohol</em>, <em>nicotine</em>, <em>caffeine</em>, <em>depression</em>, <em>dependence</em>, <em>Withdrawal</em></span></div></div><div id="idm140379477192240" lang="es" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140379477192240title">Abstract</h2><!--article-meta--><div><p id="__p2">El alcohol, la nicotina y la cafe&#x000ed;na son las sustancias psicotr&#x000f3;picas utilizadas m&#x000e1;s ampliamente en todo el mundo. Ellas son consumidas en gran cantidad por sujetos normales y su utilizaci&#x000f3;n es mucho m&#x000e1;s frecuente en los pacientes psiqui&#x000e1;tricos. De hecho los pacientes esquizofr&#x000e9;nicos tienden a abusar de estas tres sustancias. Las interrelaciones entre depresi&#x000f3;n y alcohol son complejas. Todas estas sustancias pueden crear dependencia, de la manera en que est&#x000e1; definida en el Manual Diagn&#x000f3;stico y Estad&#x000ed;stico de los Trastornos Mentales, 4<sup>a</sup> edici&#x000f3;n (DSM-IV). El abuso de alcohol es claramente delet&#x000e9;reo para el cerebro, provocando trastornos mentales agudos y cr&#x000f3;nicos, que van desde la intoxicaci&#x000f3;n con deterioro cognitivo hasta el delirium tremens, la alucinosis y la demencia. En cambio, las principales consecuencias para la salud de la nicotina, especialmente el c&#x000e1;ncer y las enfermedades cardiovasculares, est&#x000e1;n fuera del dominio de la psiquiatr&#x000ed;a. Sin embargo, el tema de la dependencia de la nicotina y la motivaci&#x000f3;n para fumar o para dejar de hacerlo le conciernen a los psiquiatras.</p></div></div><div id="idm140379483522880" lang="fr" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140379483522880title">Résumé</h2><!--article-meta--><div><p id="__p3">Alcool, nicotine et caf&#x000e9;ine sont les substances psychotropes les plus largement utilis&#x000e9;es &#x000e0; travers le monde. Si elles sont largement consomm&#x000e9;es par les individus normaux, leur utilisation est encore plus fr&#x000e9;quente chez les patients psychiatriques. Ainsi, les schizophr&#x000e8;nes ont tendance &#x000e0; abuser de ces trois substances. Par ailleurs, les relations mutuelles entre d&#x000e9;pression et alcool sont complexes. Ces substances peuvent &#x000ea;tre &#x000e0; l'origine d'une d&#x000e9;pendance, ainsi qu'elle est d&#x000e9;finie dans le Manuel Diagnostique et Statistique des Troubles Mentaux, 4<sup>e</sup> &#x000e9;dition (DSM-IV). L'abus d'alcool est clairement d&#x000e9;l&#x000e9;t&#x000e8;re pour le cerveau, provoquant des troubles mentaux aigus et chroniques allant de l'intoxication avec d&#x000e9;ficit de la cognition, au delirium tremens, &#x000e0; l'hallucinose et &#x000e1; la d&#x000e9;mence. En revanche, les principales cons&#x000e9;quences de la nicotine en termes de sant&#x000e9;, notamment cancer et maladies cardio-vasculaires, sont hors du domaine de la psychiatrie. Il n'en reste pas moins que le probl&#x000e8;me de la d&#x000e9;pendance &#x000e0; la nicotine et la motivation pour fumer ou s'arr&#x000ea;ter font partie des pr&#x000e9;occupations des psychiatres.</p></div></div><div id="idm140379485130096" class="tsec sec headless whole_rhythm"><p id="__p4" class="p p-first">Alcohol, nicotine, and caffeine share several common features. Being palatable for their mild psychotropic properties, they are the most widely consumed drugs worldwide. As licit psychoactive drugs, they are used mostly by &#x0201c;normal&#x0201d; people, in contrast to Illicit &#x0201c;hard drugs,&#x0201d; which are traditionally viewed as the province of the deviant. Known to mankind for several centuries, alcohol, nicotine, and caffeine have become an important part of culture, serving as a vehicle for social Interaction, shaping the urban landscape with dedicated places - from the Ottoman coffeehouse to the German Brauhaus and the Parisian caf&#x000e9; - stimulating the opening of International trade routes and bringing substantial tax revenues to governments. Abnormal patterns of substance use have been described since antiquity Aristotle recorded the effects of alcohol withdrawal and warned that drinking could be Injurious during pregnancy<sup><a href="#ref1" rid="ref1" class=" bibr popnode">1</a></sup>; the Roman physician Celsus held that dependence on intoxicating drink was a disease.<sup><a href="#ref2" rid="ref2" class=" bibr popnode">2</a></sup> Today, alcohol and nicotine are public health problems because of their association with physical ailments such as cirrhosis, cancer, and cardiovascular disease. Of these three substances, only alcohol causes clear neuropsychiatrie sequelae. Frequent heavy drinking, especially when associated with malnutrition, has been shown to lead to central nervous system (CNS) deterioration. The <em>Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV),<sup><a href="#ref3" rid="ref3" class=" bibr popnode">3</a></sup></em> the current nomenclature of the American Psychiatric Association, has specific diagnostic categories for alcohol-, nicotine-, and caffeine-related disorders. According to <em>DSM-IV'</em>s definition, all three substances can Induce dependence. Conversely, patients presenting with various mental disorders may be more prone than the general population to use or abuse these three common substances. Thus, patients with bipolar depression are more likely to abuse alcohol at certain times In the course of their Illness. Patients with schizophrenia have high rates of consumption of all three substances, which they use to relieve dysphoria.<sup><a href="#ref4" rid="ref4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212338">4</a></sup>
</p></div><div id="__sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec1title">Alcohol</h2><p id="__p5" class="p p-first">The consumption of alcoholic beverages, In the form of beer or wine, Is mentioned In the records of the earliest known civilizations. Physicians' prescriptions of beer were found on Sumerlan clay tablets (c 2100 bc). Egyptian doctors In their medical papyri (c 1500 bc) Included beer or wine In about 15% of their prescriptions.<sup><a href="#ref5" rid="ref5" class=" bibr popnode">5</a></sup> Alcohol - an Inebriating substance - is consumed because It relieves the mind from anxiety and Inhibitions. In the 19th century medical literature, alcohol was recognized as a major cause of mental morbidity, and the phenomenology of acute and chronic alcoholism was already well known. Ball,<sup><a href="#ref6" rid="ref6" class=" bibr popnode">6</a></sup> a renowned professor of psychiatry in Paris, wrote in 1880 that &#x0201c;of all the poisons that, to a variable degree, exert a deleterious Influence on the constitution, alcohol Is without doubt the substance whose effects have been most thoroughly described and meticulously Investigated.&#x0201d;</p><div id="__sec2" class="sec"><h3 id="__sec2title">Alcohol and the <em>DSM-IV</em> classification</h3><p id="__p6" class="p p-first-last">
<em>DSM-IV</em> offers two categories of <em>alcohol use disorders: alcohol abuse</em> and <em>alcohol dependence.</em> Abuse Is a maladaptive pattern of drinking, resulting In adverse consequences (neglect of children or work, marital problems) or dangerous behavior (driving while drunk). Dependence Is Indicated by loss of control and continued drinking despite alcohol-related problems, and by evidence of tolerance or symptoms of withdrawal Typically, the dependent subject wants to stop drinking but cannot, and morning drinking Is characteristic. The disorders Induced by alcohol are well known, and will not be detailed here. <em>DSM-IV</em> lists withdrawal delirium (delirium tremens), psychotic disorders with delusions or hallucinations, persisting dementia, and persisting amnestic disorder. Recognizing the frequent association between alcohol and depression, <em>DSM-W</em> also Includes the category <em>alcohol-induced mood disorder</em> to diagnose mood disorders developing during, or within a month, of alcohol intoxication or withdrawal.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Depression ami alcohol</h3><p id="__p7" class="p p-first">The Interrelationship between depression and alcohol Is complex, but highly Important in clinical practice. About 100 years ago, the readers of a booklet written by Bode, a German physician,<sup><a href="#ref7" rid="ref7" class=" bibr popnode">7</a></sup> could learn that depression and alcohoi abuse are often linked. The author thought that regular drinking could be a consequence of the &#x0201c;depression&#x0201d; caused by an unfavorable climate, stating for instance that alcoholism had been observed in Italians moving to the fog and rain of London, or in German colonial officers posted In tropical countries. In a more modern vein, Bode also added that alcohol abuse could be one of the first symptoms of &#x0201c;melancholia,&#x0201d; the usual term at the time for today's major depression. He wrote that the melancholic patient &#x0201c;turned to the bottle&#x0201d; to alleviate feelings of anxiety, guilt, sorrow, sadness, and mental vacuity. This statement would still be considered pertinent today Intuitively, the association between depression and alcohol seems to have good face value. However, this association Is much more complex than meets the eye. Interestingly, a Ushaped relationship of depression and alcohol consumption has been observed In large population samples. It was found that lower-level drinkers had lower depression scores than both nondrinkers and heavy drinkers.<sup><a href="#ref8" rid="ref8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212313">8</a></sup> The fact that moderate alcohol users are merrier than teetotalers Is Illustrated by Sir John's comment in Shakespeare's play, <em>Henry IV, Part 2</em> (act 4): &#x0201c;A man cannot make him laugh; but that's no marvel; he drinks no wine.&#x0201d;</p><p id="__p8">The causal element In the association between depression and alcoholism is debatable. Is depression secondary to alcoholism, or vice versa? Or, are both possible? In the case of alcohol-Induced mood disturbances, alcoholism Is clearly primary, and depression secondary. Mood disturbances are characteristic of heavy drinkers, particularly during withdrawal. When not drinking, alcoholics often report depression, Irritability, suspiciousness, lethargy, apprehension, anxiety, and poor concentration. About a quarter of recently detoxified alcoholics have a depressive syndrome. <em>Alcohol-induced depression</em> usually remits In less than 1 month without specific treatment. The clinical course of depression when it coexists with alcoholism Is generally benign and self-limited, with most patients becoming euthymlc within 2 to 3 weeks of abstention without antidepressant treatment. In some depressed alcoholics, however, a more chronic depression persists, and may predict a worse outcome for the alcoholism. In that case, antidepressants should definitely be used, since they may lower the relapse rate.</p><p id="__p9">The reverse of alcohol-Induced depression, namely <em>depression-induced alcoholism,</em> can also be observed. Drinking may be secondary to depression, when alcohol Is used as self -medication by the patient. The alcoholic may drink to relieve his mind from sorrow, fear, and despondency, or to combat loneliness or the blues. Since alcohol absorption may have a transient arousing or mood-lifting effect, this strategy has some short-term benefit, but It Is doomed in the long run. In fact, as described In the paragraph above, the paradox is that chronic use of alcohol Is more likely to make the subject more withdrawn, more depressed, or more anxious. However, It should be remembered that, although depression can lead to alcoholism, most cases of alcoholism are not explained by primary depression, contrary to popular belief.</p><p id="__p10">A primary mood disorder should be particularly suspected In certain circumstances, notably In females and In the cases of early-onset drinking. Also, the possibility of bipolar disorder should be kept In mind.</p><p id="__p11">Women may be more at risk than men to develop this form of secondary alcoholism. The hypothesis that depressive symptoms predicted subsequent alcohol problems for females, whereas alcohol problems predicted subsequent depressive symptoms for males, was tested In a random sample of 1306 adults from Erie County, New York, assessed In 1986, 1989, and 1993. <sup><a href="#ref9" rid="ref9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212318">9</a></sup> Measures of alcohol problems In the previous year included an alcohol abuse/dependence diagnosis and a heavy alcohol use Index. The Center for Epidemiologic Studies Depression Scale was used to assess depressive symptoms over 1 month. For females, depressive symptoms predicted subsequent alcohol problems over 3 years (odds ratio 3.04; 95% confidence Interval [CI] 1.35-6.80; P&#x0003c;0.01) and 4 years (odds ratio 2.42; 95% CI 1.14-5.12; P&#x0003c;0.05), but not for 7 years. Similarly, another study showed that the risk of heavy drinking was 2.6 times greater In women with a history of depressive disorder than in women with no history of depressive disorder.<sup><a href="#ref10" rid="ref10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212320">10</a></sup>
</p><p id="__p12" class="p p-last">Early-onset drinking may often be secondary to a primary psychiatric disorder. This notion Is supported by a study<sup><a href="#ref11" rid="ref11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212345">11</a></sup> that found that 81% of 339 alcoholics had associated mental disorders. Alcoholics with onset of heavy drinking before 20 years of age had significantly more antisocial personality traits, drug abuse, bipolar disorder, panic disorder, suicide attempts, and paternal alcoholism than alcoholics with onset after age 20 years. Alcoholics with onset before and after 20 years of age also differed significantly from each other for cerebrospinal fluid concentrations of somatostatin.</p></div><div id="__sec4" class="sec"><h3 id="__sec4title">Bipolar disorder</h3><p id="__p13" class="p p-first-last">It Is too often ignored that episodic drinking may be a symptom of bipolar illness. In a recent study,<sup><a href="#ref12" rid="ref12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212336">12</a></sup> the independent familial aggregation of bipolar disorder and alcoholism, and the finding that the onset of bipolar disorder tended to precede that of alcoholism, were compatible with a self-medication hypothesis as the explanation for the frequent cooccurrence of these disorders; In contrast, the independent familial aggregation and the tendency toward an earlier onset of alcoholism than that of nonbipolar depression suggest that unipolar mood disorders are frequently secondary to alcoholism. Other authors<sup><a href="#ref13" rid="ref13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361051">13</a></sup> evaluating the prevalence of substance abuse and dependence among subjects with bipolar I disorder versus bipolar II disorder found that alcohol was the most commonly abused drug among both bipolar I and bipolar II subjects; bipolar I subjects appear to have higher rates of substance abuse and dependence than bipolar II subjects.</p></div><div id="__sec5" class="sec"><h3 id="__sec5title">Genetics of alcoholism</h3><p id="__p14" class="p p-first">An association between alcohol and depression can be inferred from the findings of numerous familial, epidemiological, and molecular genetics studies. Adoption and twin studies had concluded, a few decades ago, that genetics exerts a small but definite effect on the development of alcoholism.<sup><a href="#ref14" rid="ref14" class=" bibr popnode">14</a></sup> An Important caveat Is the difficulty of discerning whether the biological mother's contribution is genetic or environmental (eg, drinking during the critical periods of gestation and nursing). Also, clinical and epidemiological studies have consistently revealed an association between alcohol use disorders and both bipolar and nonbipolar mood disorders. However, the evidence regarding the nature of this association is unclear. Wlnokur<sup><a href="#ref15" rid="ref15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212361">15</a></sup> advanced the &#x0201c;depressive spectrum&#x0201d; hypothesis, on the basis of his findings that persons developing unipolar depression prior to age 40 had more alcoholism and antisocial personality In their male relatives. However, subsequent researchers who Investigated the relatives of patients with unipolar or bipolar depression were unable to replicate a genetic association between mood disorders and drinking. There is a consensus that genetic factors play a role in the vulnerability to mood disorder, and It Is likely that hereditary factors Influence the appearance of alcoholism too. However, both class of disorders are probably influenced by distinct genetic factors. Data on family studies or genetic studies generally suggest that alcoholism and depression are two independent Illnesses, albeit both quite common. Individual differences in the pharmacokinetics and pharmacodynamics of alcohol were known long before the advent of molecular genetics. Men metabolize a significant fraction of alcohol in the stomach prior to absorption, In contrast to women who have less active stomach enzymes. Alcohol is absorbed Into the bloodstream through the stomach (20%) and Intestine (80%). In women, alcohol absorption through the stomach is higher premenstrually and during ovulation.<sup><a href="#ref16" rid="ref16" class=" bibr popnode">16</a></sup> Up to 90% of alcohol consumed Is metabolized In the liver. The rapidly developing tolerance to some of the effects of alcohol Is partly attributable to enzyme Induction In the liver. The ability to metabolize acetaldehyde, a compound produced by the catabolic breakdown of alcohol, is impaired in some Japanese or Chinese Individuals, resulting In flushing and discomfort after moderate amounts of alcohol.</p><p id="__p15" class="p p-last">Molecular genetics made it possible to Identify polymorphisms In genes that Intervene In the pharmacokinetics of alcohol (eg, the enzymes aldehyde dehydrogenase and alcohol dehydrogenase).<sup><a href="#ref17" rid="ref17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212324">17</a></sup> Recent research findings have shown the genetic association or linkage of alcoholism to genes that also play a role In other psychiatric disorders and In the response to drug treatment. Examples Include the association of alcoholism with the y-amlnobutyric acid receptor GABA<sub>A</sub>
<sup><a href="#ref18" rid="ref18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212359">18</a></sup> (GAB A is the major inhibitory neurotransmitter of the CNS); the linkage of suicidally, severe suicide attempts, and alcoholism to the tryptophan hydroxylase gene<sup><a href="#ref19" rid="ref19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212312">19</a></sup> (the rate-limiting enzyme in the synthesis of serotonin [5-hydroxytryptamine, 5-HT]); the linkage of antisocial alcoholism to the autoreceptor 5-HT<sub>1B</sub> gene<sup><a href="#ref20" rid="ref20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212322">20</a></sup>; and the linkage of severe and antisocial alcoholism to the dopamine D<sub>2</sub> and D<sub>4</sub> receptor genes.<sup><a href="#ref21" rid="ref21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212349">21</a></sup>
</p></div><div id="__sec6" class="sec sec-last"><h3 id="__sec6title">Alcoholism and drug treatment</h3><p id="__p16" class="p p-first">Alcohol Interferes with the central metabolism of the neurotransmitters - especially indolamines - involved In the pathophysiology and drug treatment of mood disorders. Several lines of research support an important role for brain 5-HT pathways in the control of alcohol drinking behavior. It Is known that drinking Increases the rate of 5-HT turnover and decreases the platelet uptake of 5-HT.<sup><a href="#ref22" rid="ref22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212315">22</a></sup> Serotonergic compounds reduce ethanol selfadministration In conditioned rats.<sup><a href="#ref23" rid="ref23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212346">23</a></sup> Results are consistent with activation of 5-HT<sub>1A</sub> and 5-HT<sub>1B</sub> receptor subtypes In mediation of the conditioned or secondary reinforcing properties of ethanol. The observation that alcohol modifies neurotransmitter function Is part of the rationale for the psychopharmacological treatment of alcoholism.</p><p id="__p17">It was shown that men and women who are diagnosed with major depression at the time that they are admitted for Inpatient treatment of alcohol dependence have shorter times to first drink and alcohol relapse.<sup><a href="#ref24" rid="ref24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212351">24</a></sup> This suggests that It is of paramount Importance to diagnose and treat comorbid depression In alcoholic patients who are seen for treatment. Antidepressants have shown efficacy In the treatment of alcoholism with comorbid depression, and sometimes even In the absence of comorbid depression. In particular, antidepressants have been helpful In the reduction of craving and relapse rates during detoxification.</p><p id="__p18">When antidepressant treatment should be started Is debatable. Antidepressant treatment should certainly be Initiated If depression persists after 2 to 4 weeks of alcohol withdrawal. However, certain authors recommend using antidepressant drugs much earlier, in order to diminish alcohol consumption, craving, and the risk of relapse. It should be kept In mind that the adverse effects of the drug may be potentiated by alcohol Intake If treatment is started early, when the patient is still drinking or when detoxification Is not complete. Also, the patient's medical condition may necessitate lower antidepressant doses. Particular attention should be paid to anticholinergic and cardiovascular adverse effects. The use of tricyclic compounds may be limited by the occurrence of hepatic and myocardial abnormalities In alcoholic patients. Also, the pharmacokinetics of the drug may be changed In the alcoholic. For Instance, Imipramlne clearance Is Increased In the alcoholic, its half -life Is shortened, and much lower plasma levels will be observed.<sup><a href="#ref25" rid="ref25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212308">25</a></sup>
</p><p id="__p19">The choice of medication Is likely to be determined by the availability of various classes of drugs, which differs between countries. Serotonergic drugs have been extensively studied in depressive alcoholics and they have proven effective In maintaining abstinence. They may, therefore, be a useful adjuvant In the therapy of alcoholism. Selective serotonin reuptake Inhibitors (SSRIs) seem to have short-term effects in alcohol dependence, and are probably more effective In men and In the presence of comorbid depression.<sup><a href="#ref26" rid="ref26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212333">26</a></sup> Citalopram<sup><a href="#ref27" rid="ref27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212342">27</a></sup> was shown to decrease alcohol consumption in nondepressed subjects with alcohol dependence. Fluoxetine<sup><a href="#ref28" rid="ref28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361048">28</a></sup> at antidepressant doses was able to prevent relapses In weaned alcoholics. Trazodone,<sup><a href="#ref29" rid="ref29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212331">29</a></sup> a relatively selective inhibitor of 5-HT reuptake, was able at low doses to significantly decrease craving for alcohol In detoxified alcohol-dependent subjects. TIaneptlne,<sup><a href="#ref30" rid="ref30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212316">30</a></sup> a compound that increases 5-HT reuptake, was shown to be particularly suitable In depressed patients after withdrawal from alcohol abuse or dependence, because of Its relative lack of sedative, anticholinergic, and cardiovascular effect. Viloxazine,<sup><a href="#ref31" rid="ref31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212335">31</a></sup> an inhibitor of norepinephrine reuptake, was shown to be superior to placebo on the reduction of alcohol consumption. Besides antidepressants, some studies Investigated the effect of mood-regulating agents. Overall, little benefit was found with lithium, whereas valproate seemed more promising.</p><p id="__p20" class="p p-last">Recently, acamprosate has been Introduced as a clinical treatment to reduce relapse In recovering alcoholics In Europe, while naltrexone has been approved for a similar use by the US Food and Drug Administration. Acamprosate exerts agonist-like effects at GABA receptors and antagonist effects at the A-methyl-D-aspartate (NMDA) receptor; its ability to modulate the expression of NMDA receptor subunlts In specific brain regions may be of relevance for Its anticravlng properties.<sup><a href="#ref32" rid="ref32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212358">32</a></sup> Naltrexone Is hypothesized to reduce ethanol consumption by blocking central opioid receptors, which in turn modulate the positive reinforcing properties of ethanol.<sup><a href="#ref33" rid="ref33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212357">33</a></sup>
</p></div></div><div id="__sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec7title">Nicotine</h2><p id="__p21" class="p p-first">Tobacco Is native to America, where It may have been cultivated by man as early as 5000 to 3000 bc.<sup><a href="#ref34" rid="ref34" class=" bibr popnode">34</a></sup> Columbus came Into contact with Indians smoking tobacco when he landed In Cuba, on his very first trip to America. The rest of the story of how the plant quickly conquered the world Is well known. Like caffeine, nicotine may be regarded as a stimulant. Nicotine Is not directly associated with psychiatric disorders, apart from the observation that psychiatric patients smoke more than the general population. Nicotine's toxicity concerns mostly the cardiovascular system and cancer. The neurotoxic and neuroprotective properties of nicotine had not been thoroughly Investigated until recently. A study In rats<sup><a href="#ref35" rid="ref35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212329">35</a></sup> has shown that nicotine produces selective degeneration In the medial habenula, a region with a dense concentration of nicotinic cholinergic receptors. A significant public health concern Is the risk to pregnant women. Prenatal exposure to tobacco probably Inflicts damage to the developing brain, as suggested by a recent study showing upregulation of nicotinic cholinergic receptors in the brains of monkeys exposed to tobacco In gestation and the early neonatal period.<sup><a href="#ref36" rid="ref36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212321">36</a></sup> Nicotine has a neuroprotective action In neurodegenerative disorders such as Parkinson's and Alzheimer's diseases. It protects neurons against the neurotoxicity caused by p-amyloid, the major component of senile plaques.<sup><a href="#ref37" rid="ref37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212341">37</a></sup>
</p><div id="__sec8" class="sec"><h3 id="__sec8title">Psychological, sociological, and biological factors associated with nicotine use</h3><p id="__p22" class="p p-first">The onset of smoking typically occurs In the teenage years. Some American studies found that the median age of initiation is 16 to 17 years.<sup><a href="#ref38" rid="ref38" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212344">38</a></sup> According to recent French epidemiological data, the mean age of smoking onset is as early as 14 years.<sup><a href="#ref39" rid="ref39" class=" bibr popnode">39</a></sup> People choose to smoke because they appreciate the psychoactive, stimulant effect of nicotine. Smokers report that smoking helps them concentrate, reason, and perform - observations consistent with studies demonstrating that nicotine improves attention, learning, reaction time, and problem solving. For example, studies suggest that nicotine Increases the speed of sensory Information processing In smokers.<sup><a href="#ref40" rid="ref40" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212337">40</a></sup> Smokers also report that smoking helps them relax, particularly In stressful situations, and improves their mood. They report pleasure and reduced anger, tension, depression, and stress. One explanation for the use of nicotine Is that smokers rely on these positive reinforcements to cope with their environment. This hypothesis is borne out by the fact that Individuals with psychiatric or psychological problems characterized by negative affect and difficulty coping are more likely to be smokers than Individuals who are more emotionally stable.<sup><a href="#ref41" rid="ref41" class=" bibr popnode">41</a></sup> The psychological and societal factors that Influence experimentation with tobacco will also Influence the propensity to experiment with other substances and, generally, different patterns of behavior. As expected, there Is an association among the use of various psychoactive substances In adolescents. For Instance, the National Household Survey conducted by the National Institute on Drug Abuse In 1985 found that, among 12- to 17-yearolds, the proportion using alcohol and marijuana was 74.2% and 47.3%, respectively, among current smokers, as compared with only 23.5% and 5.8%, respectively, among nonsmokers. Similarly, a recent Canadian study of 13 549 students showed that adolescents who used alcohol or cannabis or who smoked cigarettes were also more likely to use stimulants (amphetamines, diet pills) for recreational purposes.<sup><a href="#ref42" rid="ref42" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212360">42</a></sup> One Important factor in smoking initiation is the example provided by parents and peers. Smoking Is more frequent among adolescents whose parents smoke or whose boyfriend or girlfriend smokes.<sup><a href="#ref43" rid="ref43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212317">43</a></sup> Societal tolerance, the absence of a clear set of rules, and the permissive attitude of some parents toward smoking also bear, without a doubt, some responsibility for Initiation of smoking in the young.</p><p id="__p23">A variety of psychological, sociological, and biological factors have a role In the progression from smoking experimentation to regular smoking. While many young people are exposed to the pleasurable effects of nicotine, only a minority go on to become regular smokers. According to a recent Sofres poll,<sup><a href="#ref44" rid="ref44" class=" bibr popnode">44</a></sup> approximately 22% of the French population aged 15 or more continues smoking despite their knowledge of the actual or potential adverse consequences. Admittedly, possessing the theoretical knowledge that a substance Is dangerous In the long term does not automatically entail that one feels emotionally, personally, and directly concerned. Psychological factors have been described by various authors, Including psychoanalysts.<sup><a href="#ref45" rid="ref45" class=" bibr popnode">45</a></sup> They include a difficulty solving Intrapsychic conflicts and resorting to acts, substances, or food to alleviate feelings of boredom, emptiness, or anxiety that cannot be elaborated psychologically Individuals who rely on cigarette smoking to cope with their environment generally consider it an efficient strategy because of Its rapidity of action (nicotine reaches the brain within seconds) and availability (purchasing cigarettes requires relatively moderate cost and effort). The psychological factors that lead to smoking are often the same factors that lead to the use of other substances. Thus, cigarette smoking Is often associated with the use of other substances, and the quantity of alcohol and nicotine consumed tends to follow parallel curves (moderate drinkers tending to be moderate smokers, and heavy drinkers tending to be heavy smokers).<sup><a href="#ref46" rid="ref46" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212352">46</a></sup> Statistically, cigarette smoking and nicotine dependence are more prevalent in persons with a history of child abuse and neglect, in children whose parents have problems with alcohol and other drugs, In single teenage mothers and their children, In children and adolescents In foster care, In school dropouts, unemployed youths,<sup><a href="#ref47" rid="ref47" class=" bibr popnode">47</a></sup> adolescents who are Incarcerated and those In vocational schools,<sup><a href="#ref48" rid="ref48" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212310">48</a></sup> and In persons with a history of incarceration. By high-school graduation, 28% of adolescents smoke cigarettes, but their peers who have dropped out of high school have rates approaching 70 %.<sup><a href="#ref49" rid="ref49" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212355">49</a></sup> In adults, smoking is more frequent among divorcees and single parents. Vulnerability factors may be undesirable states from which relief Is sought. Resorting or not to smoking - or to other substances - in order to deal with life stressors or boredom Is largely determined by an Individual's repertoire of coping mechanisms. Delinquent behavior and experimentation with liquor, beer, and marijuana are also associated with teenage smoking. Smoking is also strongly linked to a variety of lifestyle indicators: it Is associated with alcohol and caffeine consumption.<sup><a href="#ref50" rid="ref50" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212319">50</a></sup>
</p><p id="__p24" class="p p-last">Whether genetic factors explain some of the variation in cigarette smoking Is not yet clear. Twin studies have produced variable estimates of the heritabllity of smoking behavior, ranging from 33% to 84% In American and Australian samples.<sup><a href="#ref51" rid="ref51" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212323">51</a>,<a href="#ref52" rid="ref52" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212325">52</a></sup> Interindlvidual differences have been shown in nicotine intake per cigarette and cotlnine (the metabolite of nicotine) half -life.<sup><a href="#ref53" rid="ref53" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_363921790">53</a></sup> CYP2A6, a genetically variable liver enzyme, is largely responsible for metabolizing nicotine to cotlnine.<sup><a href="#ref54" rid="ref54" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212314">54</a></sup> One study found that subjects carrying one or two Inactive CYP2A6 alleles have Impaired nicotine metabolism and are underrepresented in tobacco-dependent populations.<sup><a href="#ref55" rid="ref55" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212326">55</a></sup> Different frequencies of the inactive CYP2A6 alleles have been reported In various populations.<sup><a href="#ref56" rid="ref56" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212347">56</a></sup> However, a recent study, based on a more exact genotyplng method, found no relation between genetic characteristics of nicotine metabolism and cigarette consumption.<sup><a href="#ref57" rid="ref57" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212311">57</a></sup> Dopamine pathways are thought to mediate the pleasurable effects of nicotine In the brain. Studies suggest a relationship between genetic polymorphisms of the dopamine D<sub>2</sub> receptor gene and the dopamine transporter gene and smoking, Indicating that these genes may belong to a multifactorial set of risk factors associated with smoking.<sup><a href="#ref58" rid="ref58" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212340">58</a>,<a href="#ref59" rid="ref59" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212348">59</a></sup> More studies will be required before these genetic issues are settled.</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Nicotine dependence</h3><p id="__p25" class="p p-first">&#x0201c;Tobacco dependence&#x0201d; was Included for the first time In the nomenclature of mental disorders with the publication of the <em>Diagnostic and Statistical Manual of Mental Disorders .Thkd</em> Edition <em>(DSM-III)</em> in 1980.<sup><a href="#ref61" rid="ref61" class=" bibr popnode">60</a></sup> The diagnosis of tobacco dependence or addiction did not exist In second edition, <strong><em>DSM-II</em></strong> (the previous classification in 1968).<sup><a href="#ref61" rid="ref61" class=" bibr popnode">61</a></sup> The definitions of dependence are based on consensus and have been repeatedly modified during the last decades. Prevalence rates of tobacco dependence are greatly Influenced by the definitions chosen. Thus, <em>DSMIII</em> criteria were so overlnclusive that a study<sup><a href="#ref62" rid="ref62" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361050">62</a></sup> of 1006 middle-aged, male smokers showed that 90% were tobacco dependent according to <strong><em>DSM-III.</em></strong> Using <em>Diagnostic and Statistical Manual of Mental Disorders,</em> Third EditionRevised <em>(DSM-III-R)<sup><a href="#ref63" rid="ref63" class=" bibr popnode">63</a></sup></em> criteria, Stanton studied the 12month prevalence rate of dependence of 967 daily cigarette-smoking 18-years-olds and found 19.3% to be dependent.<sup><a href="#ref64" rid="ref64" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212343">64</a></sup> In <strong><em>DSM-IV,<sup><a href="#ref3" rid="ref3" class=" bibr popnode">3</a></sup></em></strong> this diagnostic category Is called &#x0201c;nicotine&#x0201d; dependence Instead of &#x0201c;tobacco&#x0201d; dependence. A similar historical evolution was observed with <em>ICD,</em> the World Health Organization's Classification of Diseases.</p><p id="__p26" class="p p-last">
<em>ICD-10,</em> published In 1992,<sup><a href="#ref65" rid="ref65" class=" bibr popnode">65</a></sup> contains a category for tobacco dependence, whereas the previous edition, <em>ICD</em> 9,<sup><a href="#ref66" rid="ref66" class=" bibr popnode">66</a></sup> devised In the mid-1970s, had no such specific category and offered only a category for nicotine abuse.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Smoking withdrawal and cessation</h3><p id="__p27" class="p p-first-last">Motivation and education are key factors. Clinical practice shows that smoking cessation can only be successful when an Individual has made up his or her mind, is motivated, and has devised a personal strategy for how and when to stop. The subjective difficulty and the degree of discomfort entailed In the process vary markedly among Individuals, from minimal In some to substantial in others. This is greatly Influenced by an Individual's psychological motivation. As part of the smoking cessation process, the smoker will have to overcome the discomfort due to dependence and will also have to reverse established habits reinforced by sociocultural factors. Individuals have to give up the Immediate and short-lived gratification provided by cigarettes, and they have to change their lifestyle and routine. The practice of smoking is In large part a habit, a learned behavior with elements of conditioning, which Is elicited by many stimuli (colors, smells, tastes, aromas, locations, times of the day such as the cigarette In the morning or after dinner, persons, familiar surroundings). Lighting up a cigarette is largely a conditioned ritual that has to be extinguished. The changes produced by withdrawal are physiological (eg, decreased heart rate), behavioral, and subjective (increased craving, le, a strong subjective drive to use the substance, anxiety, Irritability, etc). The prevalence of signs and symptoms at 2 days postcessation In individuals who quit smoking without assistance (self-quitters) is as follows<sup><a href="#ref67" rid="ref67" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212356">67</a></sup>: anxiety 49%; craving 37%; decreased heart rate 61%; depression 31%; difficulty concentrating 43%; hunger 53%; Irritability 38%; nocturnal awakening 39%; restlessness 46%. Most symptoms begin 6 to 12 hours following smoking cessation, peak In 1 to 3 days, and last on average 3 to 4 weeks.<sup><a href="#ref68" rid="ref68" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212339">68</a></sup> Craving and hunger are generally the only remaining symptoms 4 weeks after cessation. The apparent degree of dependence and severity of withdrawal symptoms are not well correlated with ultimate success In smoking cessation.</p></div><div id="__sec11" class="sec"><h3 id="__sec11title">Decline In the prevalence of smoking</h3><p id="__p28" class="p p-first-last">A decline In the prevalence of smoking has been witnessed since the 1950s. According to a Sofres poll,<sup><a href="#ref43" rid="ref43" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212350">43</a></sup> exsmokers are more numerous than current smokers In the French population (27% and 22% of the population, respectively). During the late 1950s, almost 80% of men In Western European countries were tobacco smokers. A prevalence of 42% was reported In the USA in 1965. Thanks In large part to educational efforts, smoking prevalence has declined to approximately 20% to 25% In many Western countries. A striking feature of the decline In cigarette smoking over the last past two decades In these countries has been the emergence of a marked socioeconomic gradient. In Britain, In 1990, only 16% of professional men and women were cigarette smokers, while 48% of men and 36% of women In unskilled manual occupations continued to smoke.<sup><a href="#ref69" rid="ref69" class=" bibr popnode">69</a></sup> This distinction cannot be explained by biological differences between the two groups<sup><a href="#ref70" rid="ref70" class=" bibr popnode">70</a></sup>; rather, It seems likely that while many people across all socioeconomic strata are potential smokers, education and prevention efforts can reduce smoking frequency. A similar trend has emerged In the USA, where smoking has declined very significantly among persons with substantial formal education. When compared with figures from 1974, 1976, and 1977, cigarette smoking prevalence had declined by 1990 to 1991 from 18.8% to 3.3% among physicians (average annual decline of 1.15 percentage points); from 31.7% to 18.3% among registered nurses (average annual decline of 0.88 percentage points); and from 37.1% to 27.2% among licensed practical nurses (average annual decline of 0.62 percentage points).<sup><a href="#ref71" rid="ref71" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212307">71</a></sup>
</p></div><div id="__sec12" class="sec sec-last"><h3 id="__sec12title">NRT and drng treatment</h3><p id="__p29" class="p p-first">Even though various treatment programs are available, most smokers quit by using their own, personally devised method, and most quit without any pharmacological or professional assistance. Nonetheless, pharmacotherapy such as nicotine replacement therapy (NRT) can be used to assist smokers who find It difficult to quit on their own. NRT Is available In the form of nicotine gum or transdermal patches. NRT facilitates the initial period of cessation by reducing the severity of withdrawal symptoms such as craving and affective discomfort. Studies have demonstrated that (I) pharmacological treatment Is efficacious - NRT doubles the success rate In some cases at 6 months of follow-up<sup><a href="#ref72" rid="ref72" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361049">72</a></sup>; (II) behavioral treatment Is Itself more efficacious than NRT; and (III) success rates are almost always higher when NRT and behavioral treatment are combined.<sup><a href="#ref73" rid="ref73" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212330">73</a></sup> In general, adding NRT to a behavioral Intervention doubles the cessation rate. However, clinical practice shows that a strong personal commitment and motivation to quit are the essential preconditions to successful abstinence and, without these, pharmacological aids will not have a significant Impact on cessation success. NRT should not be considered If motivation, the mainstay of smoking cessation, is not clearly present. One Important limitation of NRT Is that the urge to smoke, or craving, is not solely determined by nicotine deprivation.<sup><a href="#ref74" rid="ref74" class=" bibr popnode">74</a></sup> As discussed earlier, the urge to use tobacco is also elicited by many environmental stimuli.</p><p id="__p30" class="p p-last">Bupropion, which was originally Introduced as an antidepressant, tends to double the abstinence rate. For Instance, In a double-blind, placebo-controlled study<sup><a href="#ref75" rid="ref75" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212353">75</a></sup> the abstinence rates at 12 months were 15.6% In the placebo group, as compared with 16.4% In the nicotine -patch group, 30.3% in the sustained-release bupropion group, and 35.5% In the group given bupropion and the nicotine patch. It has been hypothesized that bupropion, a weak inhibitor of synaptic reuptake of dopamine, may maintain stimulation of pleasure response areas In the absence of nicotine by enhancing dopamine activity In the nucleus accumbens.</p></div></div><div id="__sec13" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec13title">Caffeine</h2><p id="__p31" class="p p-first">Tea and coffee are major sources of caffeine. Caffeine Is also found In mat&#x000e9;, In small concentrations In cocoa, and In caffelnated soft drinks. Coffee originates from Ethiopia. It was In widespread use throughout the Islamic world by the end of the 15th century. A couple of centuries later, Europeans started cultivating the plants In their colonies. The history of tea Is considerably older, since It was already being planted and processed In China around the 3rd century AD. It Is estimated that an average cup of coffee contains 100 mg caffeine, whereas a cup of tea or a 0.3 L glass of cola beverage contains about 40% of that amount.</p><div id="__sec14" class="sec"><h3 id="__sec14title">Caffeine use</h3><p id="__p32" class="p p-first">Approximately 80% of the inhabitants of affluent countries drink coffee or tea daily. Caffeine Is appreciated because it Is a stimulant; It induces alertness, elevates mood, and facilitates Ideation. Subjectively, caffeine Increases feelings of well-being, motivation for work, and desire to socialize. Blockade of A<sub>1</sub> and A<sub>2a</sub> adenosine receptors appears to be the most likely mechanism of action for caffeine In brain.<sup><a href="#ref76" rid="ref76" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212332">76</a></sup>
</p><p id="__p33">Patients with schizophrenia have high caffeine intakes.<sup><a href="#ref77" rid="ref77" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361046">77</a></sup> In nonhumans, caffeine enhances dopamine function by blocking the A<sub>2a</sub> adenosine receptor. Thus, caffeine might be expected to worsen positive symptoms and Improve negative symptoms.</p><p id="__p34" class="p p-last">Caffeine consumption seems to be Influenced by genetic factors, to the same degree as alcohol and nicotine. A study in 486 monozygotic and 335 dizygotic female twin pairs showed that the resemblance for total caffeine consumption, heavy caffeine use, caffeine intoxication, caffeine tolerance, and caffeine withdrawal was substantially greater In monozygotic than In dizygotic twins,<sup><a href="#ref78" rid="ref78" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361045">78</a></sup> and the heritability of caffeine consumption was estimated at 35% to 77%.</p></div><div id="__sec15" class="sec"><h3 id="__sec15title">Caffeine dependence</h3><p id="__p35" class="p p-first-last">
<em>DSM-IV</em> has diagnostic categories for caffeine intoxication, and caffeine-induced anxiety and sleep disorder.<sup><a href="#ref3" rid="ref3" class=" bibr popnode">3</a></sup> The existence of caffeine dependence Is debated. <em>DSM-TV</em> criteria for substance dependence, as applied to caffeine, are often met In the general population. For Instance, about one quarter of 21 adolescents who consumed caffeine daily met these criteria in a study in New England.<sup><a href="#ref79" rid="ref79" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212309">79</a></sup> A study of the generic <em>DSM-IV</em> criteria for dependence In 162 caffeine users found that the &#x0201c;strong desire or unsuccessful attempt to stop use&#x0201d; criterion was endorsed by 56% of interviewees.<sup><a href="#ref80" rid="ref80" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212327">80</a></sup>
<em>DSM-IV-IR,<sup><a href="#ref81" rid="ref81" class=" bibr popnode">81</a></sup></em> the recently published text revision of <em>DSM-IV,</em> proposes research criteria for caffeine withdrawal.</p></div><div id="__sec16" class="sec sec-last"><h3 id="__sec16title">Caffeine withdrawal</h3><p id="__p36" class="p p-first">One of the reasons for proposing caffeine as a model of dependence-Inducing drug Is the fact that it Induces withdrawal symptoms, although they are limited. Like nicotine, caffeine use Is reinforced by the taste and smell of coffee, the hedonlc psychoactive effect of mental stimulation, and the desire to avoid the discomfort of withdrawal. The severity of withdrawal symptoms Increases with the caffeine maintenance dose. Even short periods of caffeine deprivation, equivalent to skipping a regular morning coffee, can produce deficit In sustained attention.<sup><a href="#ref82" rid="ref82" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212354">82</a></sup> Withdrawal symptoms are rapidly relieved by caffeine Intake. Signs and symptoms of withdrawal, In decreasing order of frequency, Include headache, drowsiness, Impaired concentration, work difficulty, depression, anxiety, irritability, nausea or vomiting, and muscle aches and stiffness.<sup><a href="#ref83" rid="ref83" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_328361047">83</a></sup> The withdrawal syndrome usually shows an onset 18 to 24 h after cessation; Its Intensity peaks between 20 to 48 h after abstinence; its duration ranges from 2 days to a week. Tolerance to the sleep-disturbing effects of caffeine has been demonstrated. However, there Is little evidence for upward dose adjustment, possibly because of the unpleasant effects of higher doses.</p><p id="__p37" class="p p-last">Since caffeine is not associated with significant health hazards or Incapacitation, Its potential to Induce dependence does not pose a serious problem for the Individual or society.</p></div></div><div id="__sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec17title">Overlapping addictions</h2><p id="__p38" class="p p-first">No psychoactive drug has been studied In so many individuals as have alcohol, nicotine, and caffeine. The experience that we have with these compounds Is tantamount to an open trial conducted over a couple of millennia In billions of subjects! This review of mankind's most consumed drugs could also have encompassed betel and khat, which are both widely consumed In Africa and Asia for their mild stimulant properties. In the near future, we are likely to gain more experience with cannabis, the use of which Is tending to be decriminalized. Since these drugs are so much appreciated, It may be assumed that they procure beneficial and pleasant effects. The benefits obtained in terms of creativity, anxiety reduction, social disinhibition, and pleasure have been extensively described In poetry and literature, rather that In medical treatises.</p><p id="__p39" class="p p-last">There exists a tendency for some normally functioning adults to have multiple addictions. This led many authors to discuss theories of addictive personality. A study<sup><a href="#ref84" rid="ref84" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_239212334">84</a></sup> of overlapping addictions to common substances (alcohol, caffeine, chocolate, or cigarettes) and activities (exercise, gambling, Internet use, television, or video games) In college men and women found moderate to large correlations, both within and between substances and activities. Several gender differences In addictive tendencies were also revealed: men scored higher than women on addiction to alcohol, cigarettes, gambling, television, and Internet use, but women scored higher on caffeine and chocolate. Animal studies have shown that rewards obtained from various drugs, as well as food, playing, and sex, stimulate a midbrain reward circuit, involving dopamine and structures such as the nucleus accumbens. The Issue of addiction Is more complex In humans, who have the conscious capacity to evaluate, In the prefrontal cortex, whether pleasurable activities are appropriate and acted upon, or should be deferred or resisted. This fascinating duality of the human, oscillating between biological urges and conscious choice, has always been a fundamental question In our history, as exemplified by the fact that our attitude toward intoxicants and games is discussed In religious texts.</p></div><div id="idm140379485571008" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140379485571008title">REFERENCES</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="ref1">1. <span class="element-citation">O'Brien JM. Alexander and Dionysius: the invisible enemy. <span><span class="ref-journal"><em>Ann Scholarship.</em> </span>1980;<span class="ref-vol">1</span>:83–105.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Scholarship.&amp;title=Alexander+and+Dionysius:+the+invisible+enemy.&amp;author=JM.+O'Brien&amp;volume=1&amp;publication_year=1980&amp;pages=83-105&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref2">2. <span class="element-citation">Berrios G., Porter R. eds. <span><span class="ref-journal"><em>A History of Clinical Psychiatry. The Origin and History of Mental Disorders. London, UK: The Athlone Press;</em> </span>1995;<span class="ref-vol">656</span></span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=A+History+of+Clinical+Psychiatry.+The+Origin+and+History+of+Mental+Disorders.+London,+UK:+The+Athlone+Press;&amp;title=eds.&amp;author=G.+Berrios&amp;author=R.+Porter&amp;volume=656&amp;publication_year=1995&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref3">3. <span class="element-citation">American Psychiatric Association. <span><span class="ref-journal"><em>Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC: American Psychiatric Association;</em> </span>1994</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostic+and+Statistical+Manual+of+Mental+Disorders.+Fourth+Edition.+Washington,+DC:+American+Psychiatric+Association;&amp;title=American+Psychiatric+Association.&amp;publication_year=1994&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref4">4. <span class="element-citation">Fowler IL., Carr VJ., Carter NT., Lewin TJ. Patterns of current and lifetime substance use in schizophrenia. <span><span class="ref-journal"><em>Schizophr Bull.</em> </span>1998;<span class="ref-vol">24</span>:443–455.</span> [<a href="/pubmed/9718636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Schizophr+Bull.&amp;title=Patterns+of+current+and+lifetime+substance+use+in+schizophrenia.&amp;author=IL.+Fowler&amp;author=VJ.+Carr&amp;author=NT.+Carter&amp;author=TJ.+Lewin&amp;volume=24&amp;publication_year=1998&amp;pages=443-455&amp;pmid=9718636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref5">5. <span class="element-citation">Alcohol consumption. <span><span class="ref-journal"><em>Encyclopaedia Britannica, http://www.britannica.com. Chicago, III: Encyclopaedia Britannica Inc. Accessed February 12,</em> </span>2003</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Encyclopaedia+Britannica,+http://www.britannica.com.+Chicago,+III:+Encyclopaedia+Britannica+Inc.+Accessed+February+12,&amp;title=Alcohol+consumption.&amp;publication_year=2003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref6">6. <span class="element-citation">Ball B. De tous les poisons qui peuvent, &#x000e0; divers degr&#x000e9;s, exercer une influence d&#x000e9;l&#x000e9;t&#x000e8;re sur l'&#x000e9;conomie, l'alcool est incontestablement celui dont les effets ont &#x000e9;t&#x000e9; le plus soigneusement d&#x000e9;crits et le plus minutieusement &#x000e9;tudi&#x000e9;s. <span><span class="ref-journal"><em>Le&#x000e7;ons sur les maladies mentales. Paris, France: Asselin et Ce;</em> </span>1880-1883;<span class="ref-vol">608</span></span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Le&#x000e7;ons+sur+les+maladies+mentales.+Paris,+France:+Asselin+et+Ce;&amp;title=De+tous+les+poisons+qui+peuvent,+&#x000e0;+divers+degr&#x000e9;s,+exercer+une+influence+d&#x000e9;l&#x000e9;t&#x000e8;re+sur+l'&#x000e9;conomie,+l'alcool+est+incontestablement+celui+dont+les+effets+ont+&#x000e9;t&#x000e9;+le+plus+soigneusement+d&#x000e9;crits+et+le+plus+minutieusement+&#x000e9;tudi&#x000e9;s.&amp;author=B.+Ball&amp;volume=608&amp;publication_year=1880-1883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref7">7. <span class="element-citation">Bode W. <span><span class="ref-journal"><em>Die Trunksucht als Krankheit und ihre Behandlung [Alcoholism as an illness and its treatment]. Weimar, Germany: W. Bodes Verlag</em>. </span>1901;<span class="ref-vol"> 15</span></span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Die+Trunksucht+als+Krankheit+und+ihre+Behandlung+[Alcoholism+as+an+illness+and+its+treatment].+Weimar,+Germany:+W.+Bodes+Verlag&amp;author=W.+Bode&amp;volume=+15&amp;publication_year=1901&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref8">8. <span class="element-citation">Rodgers B., Korten AE., Jorm AF., et al. Risk factors for depression and anxiety in abstainers, moderate drinkers and heavy drinkers. <span><span class="ref-journal"><em>Addiction.</em> </span>2000;<span class="ref-vol">12</span>:1833–1845.</span> [<a href="/pubmed/11177498" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Addiction.&amp;title=Risk+factors+for+depression+and+anxiety+in+abstainers,+moderate+drinkers+and+heavy+drinkers.&amp;author=B.+Rodgers&amp;author=AE.+Korten&amp;author=AF.+Jorm&amp;author=+et+al.&amp;volume=12&amp;publication_year=2000&amp;pages=1833-1845&amp;pmid=11177498&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref9">9. <span class="element-citation">Moscato BS., Russell M., Zielezny M., et al. Gender differences in the relation between depressive symptoms and alcohol problems: a longitudinal perspective. <span><span class="ref-journal"><em>Am J Epidemiol.</em> </span>1997;<span class="ref-vol">146</span>:966–967.</span> [<a href="/pubmed/9400339" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Epidemiol.&amp;title=Gender+differences+in+the+relation+between+depressive+symptoms+and+alcohol+problems:+a+longitudinal+perspective.&amp;author=BS.+Moscato&amp;author=M.+Russell&amp;author=M.+Zielezny&amp;author=+et+al.&amp;volume=146&amp;publication_year=1997&amp;pages=966-967&amp;pmid=9400339&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref10">10. <span class="element-citation">Dixit AR., Crum RM. Prospective study of depression and the risk of heavy alcohol use in women. <span><span class="ref-journal"><em>Am J Psychiatry.</em> </span>2000;<span class="ref-vol">157</span>:751–758.</span> [<a href="/pubmed/10784468" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psychiatry.&amp;title=Prospective+study+of+depression+and+the+risk+of+heavy+alcohol+use+in+women.&amp;author=AR.+Dixit&amp;author=RM.+Crum&amp;volume=157&amp;publication_year=2000&amp;pages=751-758&amp;pmid=10784468&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref11">11. <span class="element-citation">Roy A., DeJong J., Lamparski D., et al. Mental disorders among alcoholics. Relationship to age of onset and cerebrospinal fluid neuropeptides. <span><span class="ref-journal"><em>Arch Gen Psychiatry.</em> </span>1991;<span class="ref-vol">48</span>:423–427.</span> [<a href="/pubmed/1673594" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry.&amp;title=Mental+disorders+among+alcoholics.+Relationship+to+age+of+onset+and+cerebrospinal+fluid+neuropeptides.&amp;author=A.+Roy&amp;author=J.+DeJong&amp;author=D.+Lamparski&amp;author=+et+al.&amp;volume=48&amp;publication_year=1991&amp;pages=423-427&amp;pmid=1673594&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref12">12. <span class="element-citation">Preisig M., Fenton BT., Stevens DE., et al. Familial relationship between mood disorders and alcoholism. <span><span class="ref-journal"><em>Compr Psychiatry.</em> </span>2001;<span class="ref-vol">42</span>:87–95.</span> [<a href="/pubmed/11244143" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Compr+Psychiatry.&amp;title=Familial+relationship+between+mood+disorders+and+alcoholism.&amp;author=M.+Preisig&amp;author=BT.+Fenton&amp;author=DE.+Stevens&amp;author=+et+al.&amp;volume=42&amp;publication_year=2001&amp;pages=87-95&amp;pmid=11244143&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref13">13. <span class="element-citation">Chengappa KN., Levine J., Gershon S., et al. Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry. <span><span class="ref-journal"><em>Bipolar Disord.</em> </span>2000;<span class="ref-vol">2(3 pt 1)</span>:191S–195S.</span> [<a href="/pubmed/11256686" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bipolar+Disord.&amp;title=Lifetime+prevalence+of+substance+or+alcohol+abuse+and+dependence+among+subjects+with+bipolar+I+and+II+disorders+in+a+voluntary+registry.&amp;author=KN.+Chengappa&amp;author=J.+Levine&amp;author=S.+Gershon&amp;author=+et+al.&amp;volume=2(3+pt+1)&amp;publication_year=2000&amp;pages=191S-195S&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref14">14. <span class="element-citation">Saunders JB., Williams R. The genetics of alcoholism: is there an inherited susceptibility to alcohol-related problems?. <span><span class="ref-journal"><em>Alcohol Alcohol.</em> </span>1983;<span class="ref-vol">49</span>:430–435.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Alcohol.&amp;title=The+genetics+of+alcoholism:+is+there+an+inherited+susceptibility+to+alcohol-related+problems?.&amp;author=JB.+Saunders&amp;author=R.+Williams&amp;volume=49&amp;publication_year=1983&amp;pages=430-435&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref15">15. <span class="element-citation">Winokur G., Cadoret R., Dorzab J., et al. Depressive disease. A genetic study. <span><span class="ref-journal"><em>Arch Gen Psychiatry.</em> </span>1971;<span class="ref-vol">24</span>:135–144.</span> [<a href="/pubmed/5539859" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry.&amp;title=Depressive+disease.+A+genetic+study.&amp;author=G.+Winokur&amp;author=R.+Cadoret&amp;author=J.+Dorzab&amp;author=+et+al.&amp;volume=24&amp;publication_year=1971&amp;pages=135-144&amp;pmid=5539859&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref16">16. <span class="element-citation">Littrell J. <span><span class="ref-journal"><em>Understanding and Treating Alcoholism. Vol. 2. Biological, Psychological and Social Aspects of Alcohol Consumption and Abuse. Hillsdale, NJ: Lawrence Erlbaum Associates;</em> </span>1991</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Understanding+and+Treating+Alcoholism.+Vol.+2.+Biological,+Psychological+and+Social+Aspects+of+Alcohol+Consumption+and+Abuse.+Hillsdale,+NJ:+Lawrence+Erlbaum+Associates;&amp;author=J.+Littrell&amp;publication_year=1991&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref17">17. <span class="element-citation">Radel M., Goldman D. Pharmacogenetics of alcohol response and alcoholism: the interplay of genes and environmental factors in thresholds for alcoholism. <span><span class="ref-journal"><em>Drug Metab Dispos.</em> </span>2001;<span class="ref-vol">29(4 pt 2)</span>:489–494.</span> [<a href="/pubmed/11259338" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos.&amp;title=Pharmacogenetics+of+alcohol+response+and+alcoholism:+the+interplay+of+genes+and+environmental+factors+in+thresholds+for+alcoholism.&amp;author=M.+Radel&amp;author=D.+Goldman&amp;volume=29(4+pt+2)&amp;publication_year=2001&amp;pages=489-494&amp;pmid=11259338&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref18">18. <span class="element-citation">Loh EW., Bail D. Role of the GABA(A)beta2, GABA(A)alpha6, GABA(A)alpha1 and GABA(A)gamma2 receptor subunit genes cluster in drug responses and the development of alcohol dependence. <span><span class="ref-journal"><em>Neurochem Int.</em> </span>2000;<span class="ref-vol">37</span>:413–423.</span> [<a href="/pubmed/10871693" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neurochem+Int.&amp;title=Role+of+the+GABA(A)beta2,+GABA(A)alpha6,+GABA(A)alpha1+and+GABA(A)gamma2+receptor+subunit+genes+cluster+in+drug+responses+and+the+development+of+alcohol+dependence.&amp;author=EW.+Loh&amp;author=D.+Bail&amp;volume=37&amp;publication_year=2000&amp;pages=413-423&amp;pmid=10871693&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref19">19. <span class="element-citation">Nielsen DA., Virkkunen M., Lappalainen J., et al. A tryptophan hydroxylase gene marker for suicidally and alcoholism. <span><span class="ref-journal"><em>Arch Gen Psychiatry.</em> </span>1998;<span class="ref-vol">55</span>:593–602.</span> [<a href="/pubmed/9672049" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry.&amp;title=A+tryptophan+hydroxylase+gene+marker+for+suicidally+and+alcoholism.&amp;author=DA.+Nielsen&amp;author=M.+Virkkunen&amp;author=J.+Lappalainen&amp;author=+et+al.&amp;volume=55&amp;publication_year=1998&amp;pages=593-602&amp;pmid=9672049&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref20">20. <span class="element-citation">Lappalainen J., Long JC., Eggert M., et al. Linkage of antisocial alcoholism to the serotonin 5-HT<sub>1B</sub> receptor gene in 2 populations. <span><span class="ref-journal"><em>Arch Gen Psychiatry.</em> </span>1998;<span class="ref-vol">55</span>:989–994.</span> [<a href="/pubmed/9819067" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry.&amp;title=Linkage+of+antisocial+alcoholism+to+the+serotonin+5-HT1B+receptor+gene+in+2+populations.&amp;author=J.+Lappalainen&amp;author=JC.+Long&amp;author=M.+Eggert&amp;author=+et+al.&amp;volume=55&amp;publication_year=1998&amp;pages=989-994&amp;pmid=9819067&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref21">21. <span class="element-citation">Hill SY., Zezza N., Wipprecht G., et al. Linkage studies of D2 and D4 receptor genes and alcoholism. <span><span class="ref-journal"><em>Am J Med Genet.</em> </span>1999;<span class="ref-vol">88</span>:676–685.</span> [<a href="/pubmed/10581489" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Med+Genet.&amp;title=Linkage+studies+of+D2+and+D4+receptor+genes+and+alcoholism.&amp;author=SY.+Hill&amp;author=N.+Zezza&amp;author=G.+Wipprecht&amp;author=+et+al.&amp;volume=88&amp;publication_year=1999&amp;pages=676-685&amp;pmid=10581489&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref22">22. <span class="element-citation">Kent TA., Campbell JL., Pazdern&#x000ef;k TL., et al. Blood platelet uptake of serotonin in men alcoholics. <span><span class="ref-journal"><em>J Stud Alcohol.</em> </span>1985;<span class="ref-vol">46</span>:357–359.</span> [<a href="/pubmed/4033134" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Stud+Alcohol.&amp;title=Blood+platelet+uptake+of+serotonin+in+men+alcoholics.&amp;author=TA.+Kent&amp;author=JL.+Campbell&amp;author=TL.+Pazdern&#x000ef;k&amp;author=+et+al.&amp;volume=46&amp;publication_year=1985&amp;pages=357-359&amp;pmid=4033134&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref23">23. <span class="element-citation">Wilson AW., Costall B., Neill JC. Manipulation of operant responding for an ethanol-paired conditioned stimulus in the rat by pharmacological alteration of the serotonergic system. <span><span class="ref-journal"><em>J Psychopharmacol.</em> </span>2000;<span class="ref-vol">14</span>:340–346.</span> [<a href="/pubmed/11198050" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Psychopharmacol.&amp;title=Manipulation+of+operant+responding+for+an+ethanol-paired+conditioned+stimulus+in+the+rat+by+pharmacological+alteration+of+the+serotonergic+system.&amp;author=AW.+Wilson&amp;author=B.+Costall&amp;author=JC.+Neill&amp;volume=14&amp;publication_year=2000&amp;pages=340-346&amp;pmid=11198050&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref24">24. <span class="element-citation">Greenfield SF., Weiss RD., Muenz LR., et al. The effect of depression on return to drinking. <span><span class="ref-journal"><em>Arch Gen Psychiatry.</em> </span>1998;<span class="ref-vol">55</span>:259–265.</span> [<a href="/pubmed/9510220" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Arch+Gen+Psychiatry.&amp;title=The+effect+of+depression+on+return+to+drinking.&amp;author=SF.+Greenfield&amp;author=RD.+Weiss&amp;author=LR.+Muenz&amp;author=+et+al.&amp;volume=55&amp;publication_year=1998&amp;pages=259-265&amp;pmid=9510220&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref25">25. <span class="element-citation">Ciraulo DA., Barnhill JG., Jaffe JH. Clinical pharmacokinetics of &#x000ee;m&#x000ef;pram&#x000ef;ne and desipramine in alcoholics and normal volunteers. <span><span class="ref-journal"><em>Clin Pharmacol Ther.</em> </span>1988;<span class="ref-vol">43</span>:509–518.</span> [<a href="/pubmed/3365915" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther.&amp;title=Clinical+pharmacokinetics+of+&#x000ee;m&#x000ef;pram&#x000ef;ne+and+desipramine+in+alcoholics+and+normal+volunteers.&amp;author=DA.+Ciraulo&amp;author=JG.+Barnhill&amp;author=JH.+Jaffe&amp;volume=43&amp;publication_year=1988&amp;pages=509-518&amp;pmid=3365915&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref26">26. <span class="element-citation">Schaffer A., Naranjo CA. Recommended drug treatment strategies for the alcoholic patient. <span><span class="ref-journal"><em>Drugs.</em> </span>1998;<span class="ref-vol">56</span>:571–585.</span> [<a href="/pubmed/9806104" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drugs.&amp;title=Recommended+drug+treatment+strategies+for+the+alcoholic+patient.&amp;author=A.+Schaffer&amp;author=CA.+Naranjo&amp;volume=56&amp;publication_year=1998&amp;pages=571-585&amp;pmid=9806104&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref27">27. <span class="element-citation">Naranjo CA., Knoke DM., Bremner KE. Variations in response to citalopram in men and women with alcohol dependence. <span><span class="ref-journal"><em>J Psychiatry Neurosci.</em> </span>2000;<span class="ref-vol">25</span>:269–275.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1407711/">PMC free article</a>]</span> [<a href="/pubmed/10863887" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Psychiatry+Neurosci.&amp;title=Variations+in+response+to+citalopram+in+men+and+women+with+alcohol+dependence.&amp;author=CA.+Naranjo&amp;author=DM.+Knoke&amp;author=KE.+Bremner&amp;volume=25&amp;publication_year=2000&amp;pages=269-275&amp;pmid=10863887&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref28">28. <span class="element-citation">Jan&#x000ef;r&#x000ef; L., Gobb&#x000ef; G., Mannelli P., et al. Effects of fluoxetine at antidepressant doses on short-term outcome of detoxified alcoholics. <span><span class="ref-journal"><em>Int Clin Psychopharmacol.</em> </span>1996;<span class="ref-vol">11</span>:109–117.</span> [<a href="/pubmed/8803648" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+Clin+Psychopharmacol.&amp;title=Effects+of+fluoxetine+at+antidepressant+doses+on+short-term+outcome+of+detoxified+alcoholics.&amp;author=L.+Jan&#x000ef;r&#x000ef;&amp;author=G.+Gobb&#x000ef;&amp;author=P.+Mannelli&amp;author=al.+et&amp;volume=11&amp;publication_year=1996&amp;pages=109-117&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref29">29. <span class="element-citation">Janiri L., Hadj&#x000ef;chr&#x000ef;stos A., Buonanno A., et al. Adjuvant trazodone in the treatment of alcoholism: an open study. <span><span class="ref-journal"><em>Alcohol Alcohol.</em> </span>1998;<span class="ref-vol">33</span>:362–365.</span> [<a href="/pubmed/9719394" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol+Alcohol.&amp;title=Adjuvant+trazodone+in+the+treatment+of+alcoholism:+an+open+study.&amp;author=L.+Janiri&amp;author=A.+Hadj&#x000ef;chr&#x000ef;stos&amp;author=A.+Buonanno&amp;author=+et+al.&amp;volume=33&amp;publication_year=1998&amp;pages=362-365&amp;pmid=9719394&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref30">30. <span class="element-citation">Malka R., Loo H., Ganry H., et al. Long-term administration of tianeptine in depressed patients after alcohol withdrawal. <span><span class="ref-journal"><em>Br J Psychiatry Suppl.</em> </span>1992;<span class="ref-vol">15</span>:66–71.</span> [<a href="/pubmed/1389025" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Br+J+Psychiatry+Suppl.&amp;title=Long-term+administration+of+tianeptine+in+depressed+patients+after+alcohol+withdrawal.&amp;author=R.+Malka&amp;author=H.+Loo&amp;author=H.+Ganry&amp;author=+et+al.&amp;volume=15&amp;publication_year=1992&amp;pages=66-71&amp;pmid=1389025&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref31">31. <span class="element-citation">Altamura AC., Mauri MC., Girardi T., et al. Alcoholism and depression: a placebo-controlled study with viloxazine. <span><span class="ref-journal"><em>Int J Clin Pharmacol Res.</em> </span>1990;<span class="ref-vol">10</span>:293–298.</span> [<a href="/pubmed/2079386" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Clin+Pharmacol+Res.&amp;title=Alcoholism+and+depression:+a+placebo-controlled+study+with+viloxazine.&amp;author=AC.+Altamura&amp;author=MC.+Mauri&amp;author=T.+Girardi&amp;author=al.+et&amp;volume=10&amp;publication_year=1990&amp;pages=293-298&amp;pmid=2079386&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref32">32. <span class="element-citation">Rammes G., Mahal B., Putzke J., et al. The anti-craving compound acamprosate acts as a weak NMDA receptor antagonist, but modulates NMDA receptor subunit expression similar to memantine and MK-801 . <span><span class="ref-journal"><em>Neuropharmacology.</em> </span>2001;<span class="ref-vol">40</span>:749–760.</span> [<a href="/pubmed/11369029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neuropharmacology.&amp;title=The+anti-craving+compound+acamprosate+acts+as+a+weak+NMDA+receptor+antagonist,+but+modulates+NMDA+receptor+subunit+expression+similar+to+memantine+and+MK-801+.&amp;author=G.+Rammes&amp;author=B.+Mahal&amp;author=J.+Putzke&amp;author=al.+et&amp;volume=40&amp;publication_year=2001&amp;pages=749-760&amp;pmid=11369029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref33">33. <span class="element-citation">Stromberg MF., Mackler SA., Volp&#x000ef;cell&#x000ef; JR., O'Brien CP. Effect of acamprosate and naltrexone, alone or in combination, on ethanol consumption. <span><span class="ref-journal"><em>Alcohol.</em> </span>2001;<span class="ref-vol">23</span>:109–116.</span> [<a href="/pubmed/11331108" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Alcohol.&amp;title=Effect+of+acamprosate+and+naltrexone,+alone+or+in+combination,+on+ethanol+consumption.&amp;author=MF.+Stromberg&amp;author=SA.+Mackler&amp;author=JR.+Volp&#x000ef;cell&#x000ef;&amp;author=CP.+O'Brien&amp;volume=23&amp;publication_year=2001&amp;pages=109-116&amp;pmid=11331108&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref34">34. <span class="element-citation">Gately I. <span><span class="ref-journal"><em>La Diva Nicotina. The Story of How Tobacco Seduced the World. London, UK: Simon &#x00026; Schuster</em>. </span>2001;<span class="ref-vol">3</span></span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=La+Diva+Nicotina.+The+Story+of+How+Tobacco+Seduced+the+World.+London,+UK:+Simon+&#x00026;+Schuster&amp;author=I.+Gately&amp;volume=3&amp;publication_year=2001&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref35">35. <span class="element-citation">Carlson J., Noguchi K., Ellison G. Nicotine produces selective degeneration in the medial habenula and fasciculus retroflexus. <span><span class="ref-journal"><em>Brain Res.</em> </span>2001;<span class="ref-vol">906</span>:127–134.</span> [<a href="/pubmed/11430869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Brain+Res.&amp;title=Nicotine+produces+selective+degeneration+in+the+medial+habenula+and+fasciculus+retroflexus.&amp;author=J.+Carlson&amp;author=K.+Noguchi&amp;author=G.+Ellison&amp;volume=906&amp;publication_year=2001&amp;pages=127-134&amp;pmid=11430869&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref36">36. <span class="element-citation">Slotk&#x000ef;n TA., Pinkerton KE., Auman JT., Qiao D., Seidler FJ. Perinatal exposure to environmental tobacco smoke upregulates nicotinic cholinergic receptors in monkey brain. <span><span class="ref-journal"><em>Dev Brain Res.</em> </span>2002;<span class="ref-vol">133</span>:175–179.</span> [<a href="/pubmed/11882347" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Dev+Brain+Res.&amp;title=Perinatal+exposure+to+environmental+tobacco+smoke+upregulates+nicotinic+cholinergic+receptors+in+monkey+brain.&amp;author=TA.+Slotk&#x000ef;n&amp;author=KE.+Pinkerton&amp;author=JT.+Auman&amp;author=D.+Qiao&amp;author=FJ.+Seidler&amp;volume=133&amp;publication_year=2002&amp;pages=175-179&amp;pmid=11882347&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref37">37. <span class="element-citation">Zanardi A., Leo G., Biagini G., Zoli M. Nicotine and neurodegeneration in aging. <span><span class="ref-journal"><em>Toxicol Lett.</em> </span>2002;<span class="ref-vol">127</span>:207–215.</span> [<a href="/pubmed/12052660" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Lett.&amp;title=Nicotine+and+neurodegeneration+in+aging.&amp;author=A.+Zanardi&amp;author=G.+Leo&amp;author=G.+Biagini&amp;author=M.+Zoli&amp;volume=127&amp;publication_year=2002&amp;pages=207-215&amp;pmid=12052660&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref38">38. <span class="element-citation">Pierce J., Gilpin E. How long will today's adolescent smoker be addicted to cigarettes?. <span><span class="ref-journal"><em>Am J Public Health.</em> </span>1996;<span class="ref-vol">86</span>:253–256.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1380339/">PMC free article</a>]</span> [<a href="/pubmed/8633747" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Public+Health.&amp;title=How+long+will+today's+adolescent+smoker+be+addicted+to+cigarettes?.&amp;author=J.+Pierce&amp;author=E.+Gilpin&amp;volume=86&amp;publication_year=1996&amp;pages=253-256&amp;pmid=8633747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref39">39. <span class="element-citation">Comit&#x000e9; Fran&#x000e7;aise d'Education pour la Sant&#x000e9; (CFES). <span><span class="ref-journal"><em>Barom&#x000e8;tre Sant&#x000e9; 1997. Vanves, France: CNAM-TS, DGS;</em> </span>1998</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Barom&#x000e8;tre+Sant&#x000e9;+1997.+Vanves,+France:+CNAM-TS,+DGS;&amp;title=Comit&#x000e9;+Fran&#x000e7;aise+d'Education+pour+la+Sant&#x000e9;+(CFES).&amp;publication_year=1998&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref40">40. <span class="element-citation">Kishimoto T., Domino EF. Effects of tobacco smoking and abstinence on middle latency auditory evoked potentials. <span><span class="ref-journal"><em>Clin Pharmacol Ther.</em> </span>1998;<span class="ref-vol">63</span>:571–579.</span> [<a href="/pubmed/9630830" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Pharmacol+Ther.&amp;title=Effects+of+tobacco+smoking+and+abstinence+on+middle+latency+auditory+evoked+potentials.&amp;author=T.+Kishimoto&amp;author=EF.+Domino&amp;volume=63&amp;publication_year=1998&amp;pages=571-579&amp;pmid=9630830&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref41">41. <span class="element-citation">Kane GP. Psychosocial factors and nicotine dependence. In: Cocores JA, ed. <span><span class="ref-journal"><em>The Clinical Management of Nicotine Dependence. New York, NY: SpringerVerlag;</em> </span>1991:28–35.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+Clinical+Management+of+Nicotine+Dependence.+New+York,+NY:+SpringerVerlag;&amp;title=Psychosocial+factors+and+nicotine+dependence.+In:+Cocores+JA,+ed.&amp;author=GP.+Kane&amp;publication_year=1991&amp;pages=28-35&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref42">42. <span class="element-citation">Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. <span><span class="ref-journal"><em>CMAJ.</em> </span>2001;<span class="ref-vol">165</span>:1039–1044.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC81538/">PMC free article</a>]</span> [<a href="/pubmed/11699699" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=CMAJ.&amp;title=Medical+and+nonmedical+stimulant+use+among+adolescents:+from+sanctioned+to+unsanctioned+use.&amp;author=C.+Poulin&amp;volume=165&amp;publication_year=2001&amp;pages=1039-1044&amp;pmid=11699699&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref43">43. <span class="element-citation">Wang MQ., Fitzhugh EC., Westerfield RC., Eddy JM. Family and peer influences on smoking behavior among American adolescents: an age trend. <span><span class="ref-journal"><em>J Adolesc Health.</em> </span>1995;<span class="ref-vol">16</span>:200–203.</span> [<a href="/pubmed/7779829" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Adolesc+Health.&amp;title=Family+and+peer+influences+on+smoking+behavior+among+American+adolescents:+an+age+trend.&amp;author=MQ.+Wang&amp;author=EC.+Fitzhugh&amp;author=RC.+Westerfield&amp;author=JM.+Eddy&amp;volume=16&amp;publication_year=1995&amp;pages=200-203&amp;pmid=7779829&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref44">44. <span class="element-citation">S'arr&#x000ea;ter de fumer: &#x000e9;tude r&#x000e9;alis&#x000e9;e aupr&#x000e8;s des anciens fumeurs. Montrouge, France: Sofres; 2001. Available at: http://www.sofres.com/etudes/sante/110601_nonfum.htm. Accessed February 12. <span>2003</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar?q=S'arr&#x000ea;ter+de+fumer:+&#x000e9;tude+r&#x000e9;alis&#x000e9;e+aupr&#x000e8;s+des+anciens+fumeurs.+Montrouge,+France:+Sofres;+2001.+Available+at:+http://www.sofres.com/etudes/sante/110601_nonfum.htm.+Accessed+February+12.+2003+" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref45">45. <span class="element-citation">Sztulman H. Vers le concept de personnalit&#x000e9;s limites addictives. <span><span class="ref-journal"><em>Ann Med Psychol.</em> </span>2001;<span class="ref-vol">159</span>:201–207.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+Med+Psychol.&amp;title=Vers+le+concept+de+personnalit&#x000e9;s+limites+addictives.&amp;author=H.+Sztulman&amp;volume=159&amp;publication_year=2001&amp;pages=201-207&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref46">46. <span class="element-citation">Batel P., Pess&#x000ef;one F., Ma&#x000ee;tre C., Rueff B. Relationship between alcohol and tobacco dependencies among alcoholics who smoke. <span><span class="ref-journal"><em>Addiction.</em> </span>1995;<span class="ref-vol">90</span>:977–980.</span> [<a href="/pubmed/7663320" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Addiction.&amp;title=Relationship+between+alcohol+and+tobacco+dependencies+among+alcoholics+who+smoke.&amp;author=P.+Batel&amp;author=F.+Pess&#x000ef;one&amp;author=C.+Ma&#x000ee;tre&amp;author=B.+Rueff&amp;volume=90&amp;publication_year=1995&amp;pages=977-980&amp;pmid=7663320&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref47">47. <span class="element-citation">Jones CL., Battjes RJ. The context and caveats of prevention research and abuse. In: Jones CL, Battjes RJ, eds. <span><span class="ref-journal"><em>Etiology of Drug Abuse: Implications for Prevention. NIDA Research Monograph No. 56. Washington, DC: USDHHS, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute on Drug Abuse;</em> </span>1985:1–12.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Etiology+of+Drug+Abuse:+Implications+for+Prevention.+NIDA+Research+Monograph+No.+56.+Washington,+DC:+USDHHS,+Public+Health+Service,+Alcohol,+Drug+Abuse,+and+Mental+Health+Administration,+National+Institute+on+Drug+Abuse;&amp;title=The+context+and+caveats+of+prevention+research+and+abuse.+In:+Jones+CL,+Battjes+RJ,+eds.&amp;author=CL.+Jones&amp;author=RJ.+Battjes&amp;publication_year=1985&amp;pages=1-12&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref48">48. <span class="element-citation">Colby SM., Tiffany ST., Shiffman S., Niaura RS. Are adolescents smokers dependent on nicotine? A review of the evidence. <span><span class="ref-journal"><em>Drug Alcohol Depend.</em> </span>2000;<span class="ref-vol">59(suppl 1)</span>:S83–S95.</span> [<a href="/pubmed/10773439" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend.&amp;title=Are+adolescents+smokers+dependent+on+nicotine?+A+review+of+the+evidence.&amp;author=SM.+Colby&amp;author=ST.+Tiffany&amp;author=S.+Shiffman&amp;author=RS.+Niaura&amp;volume=59(suppl+1)&amp;publication_year=2000&amp;pages=S83-S95&amp;pmid=10773439&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref49">49. <span class="element-citation">Moolchan ET., Ernst M., Henn&#x000ef;ngfield JE. A review of tobacco smoking in adolescents: treatment implications. <span><span class="ref-journal"><em>J Am Acad Child Adolesc Psychiatry.</em> </span>2000;<span class="ref-vol">39</span>:682–693.</span> [<a href="/pubmed/10846302" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Am+Acad+Child+Adolesc+Psychiatry.&amp;title=A+review+of+tobacco+smoking+in+adolescents:+treatment+implications.&amp;author=ET.+Moolchan&amp;author=M.+Ernst&amp;author=JE.+Henn&#x000ef;ngfield&amp;volume=39&amp;publication_year=2000&amp;pages=682-693&amp;pmid=10846302&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref50">50. <span class="element-citation">Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance?. <span><span class="ref-journal"><em>Psychopharmacology.</em> </span>1993;<span class="ref-vol">110</span>:45–52.</span> [<a href="/pubmed/7870897" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology.&amp;title=Does+caffeine+intake+enhance+absolute+levels+of+cognitive+performance?.&amp;author=MJ.+Jarvis&amp;volume=110&amp;publication_year=1993&amp;pages=45-52&amp;pmid=7870897&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref51">51. <span class="element-citation">Maes HH., Woodard CE., Murrelle L., et al. Tobacco, alcohol and drug use in eight- to sixteen-year-old twins: the Virginia Twin Study of Adolescent Behavioral Development. <span><span class="ref-journal"><em>J Stud Alcohol.</em> </span>1990;<span class="ref-vol">60</span>:293–305.</span> [<a href="/pubmed/10371255" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Stud+Alcohol.&amp;title=Tobacco,+alcohol+and+drug+use+in+eight-+to+sixteen-year-old+twins:+the+Virginia+Twin+Study+of+Adolescent+Behavioral+Development.&amp;author=HH.+Maes&amp;author=CE.+Woodard&amp;author=L.+Murrelle&amp;author=+et+al.&amp;volume=60&amp;publication_year=1990&amp;pages=293-305&amp;pmid=10371255&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref52">52. <span class="element-citation">Heath AC., Cates R., Martin NG., et al. Genetic contribution to risk of smoking initiation: comparisons across birth cohorts and across cultures. <span><span class="ref-journal"><em>J Subst Abuse.</em> </span>1993;<span class="ref-vol">5</span>:221–246.</span> [<a href="/pubmed/8312729" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Subst+Abuse.&amp;title=Genetic+contribution+to+risk+of+smoking+initiation:+comparisons+across+birth+cohorts+and+across+cultures.&amp;author=AC.+Heath&amp;author=R.+Cates&amp;author=NG.+Martin&amp;author=+et+al.&amp;volume=5&amp;publication_year=1993&amp;pages=221-246&amp;pmid=8312729&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref53">53. <span class="element-citation">Perez-Stable EJ., Herrera B., Jacob P 3rd., Benowitz NL. Nicotine metabolism and intake in black and white smokers. <span><span class="ref-journal"><em>JAMA.</em> </span>1998;<span class="ref-vol">280</span>:179–180.</span> [<a href="/pubmed/9669788" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA.&amp;title=Nicotine+metabolism+and+intake+in+black+and+white+smokers.&amp;author=EJ.+Perez-Stable&amp;author=B.+Herrera&amp;author=P+3rd.+Jacob&amp;author=NL.+Benowitz&amp;volume=280&amp;publication_year=1998&amp;pages=179-180&amp;pmid=9669793&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref54">54. <span class="element-citation">Nakajima M., Yamamoto T., Nunoya K., et al. Role of human cytochrome P4502A6 in C-oxidation of nicotine. <span><span class="ref-journal"><em>Drug Metab Dispos.</em> </span>1996;<span class="ref-vol">24</span>:1212–1217.</span> [<a href="/pubmed/8937855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos.&amp;title=Role+of+human+cytochrome+P4502A6+in+C-oxidation+of+nicotine.&amp;author=M.+Nakajima&amp;author=T.+Yamamoto&amp;author=K.+Nunoya&amp;author=+et+al.&amp;volume=24&amp;publication_year=1996&amp;pages=1212-1217&amp;pmid=8937855&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref55">55. <span class="element-citation">Pianezza ML., Sellers EM., Tyndale RF. Nicotine metabolism defect reduces smoking. <span><span class="ref-journal"><em>Nature.</em> </span>1999;<span class="ref-vol">393</span>:750.</span> [<a href="/pubmed/9655391" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature.&amp;title=Nicotine+metabolism+defect+reduces+smoking.&amp;author=ML.+Pianezza&amp;author=EM.+Sellers&amp;author=RF.+Tyndale&amp;volume=393&amp;publication_year=1999&amp;pages=750&amp;pmid=9655391&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref56">56. <span class="element-citation">Oscarson M. Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene: implications for interindividual differences in nicotine metabolism. <span><span class="ref-journal"><em>Drug Metab Dispos.</em> </span>2001;<span class="ref-vol">29</span>:91–95.</span> [<a href="/pubmed/11159795" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Metab+Dispos.&amp;title=Genetic+polymorphisms+in+the+cytochrome+P450+2A6+(CYP2A6)+gene:+implications+for+interindividual+differences+in+nicotine+metabolism.&amp;author=M.+Oscarson&amp;volume=29&amp;publication_year=2001&amp;pages=91-95&amp;pmid=11159795&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref57">57. <span class="element-citation">Loriot MA., Rebuissou S., Oscarson M., et al. Genetic polymorphisms of cytochrome P450 2A6 in a case-control study on lung cancer in a French population. <span><span class="ref-journal"><em>Pharmacogenetics.</em> </span>2001;<span class="ref-vol">11</span>:39–44.</span> [<a href="/pubmed/11207029" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics.&amp;title=Genetic+polymorphisms+of+cytochrome+P450+2A6+in+a+case-control+study+on+lung+cancer+in+a+French+population.&amp;author=MA.+Loriot&amp;author=S.+Rebuissou&amp;author=M.+Oscarson&amp;author=+et+al.&amp;volume=11&amp;publication_year=2001&amp;pages=39-44&amp;pmid=11207029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref58">58. <span class="element-citation">Lerman C., Caporaso NE., Audrain J., et al. Evidence suggesting the role of specific genetic factors in cigarette smoking. <span><span class="ref-journal"><em>Health Psychol.</em> </span>1999;<span class="ref-vol">18</span>:14–20.</span> [<a href="/pubmed/9925041" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Health+Psychol.&amp;title=Evidence+suggesting+the+role+of+specific+genetic+factors+in+cigarette+smoking.&amp;author=C.+Lerman&amp;author=NE.+Caporaso&amp;author=J.+Audrain&amp;author=+et+al.&amp;volume=18&amp;publication_year=1999&amp;pages=14-20&amp;pmid=9925041&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref59">59. <span class="element-citation">Comings DE., Ferry L., Bradshaw-Robinson S., Burchette R., Chiu C., Muhleman D. The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. <span><span class="ref-journal"><em>Pharmacogenetics.</em> </span>1996;<span class="ref-vol">6</span>:73–79.</span> [<a href="/pubmed/8845863" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Pharmacogenetics.&amp;title=The+dopamine+D2+receptor+(DRD2)+gene:+a+genetic+risk+factor+in+smoking.&amp;author=DE.+Comings&amp;author=L.+Ferry&amp;author=S.+Bradshaw-Robinson&amp;author=R.+Burchette&amp;author=C.+Chiu&amp;volume=6&amp;publication_year=1996&amp;pages=73-79&amp;pmid=8845863&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref60">60. <span class="element-citation">American Psychiatric Association. <span><span class="ref-journal"><em>Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC: American Psychiatric Association;</em> </span>1980</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostic+and+Statistical+Manual+of+Mental+Disorders.+3rd+ed.+Washington,+DC:+American+Psychiatric+Association;&amp;title=American+Psychiatric+Association.&amp;publication_year=1980&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref61">61. <span class="element-citation">American Psychiatric Association. <span><span class="ref-journal"><em>Diagnostic and Statistical Manual of Mental Disorders. 2nd ed. Washington, DC: American Psychiatric Association;</em> </span>1968</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostic+and+Statistical+Manual+of+Mental+Disorders.+2nd+ed.+Washington,+DC:+American+Psychiatric+Association;&amp;title=American+Psychiatric+Association.&amp;publication_year=1968&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref62">62. <span class="element-citation">Hughes JR., Gust SW., Pechacek TF. Prevalence of tobacco dependence and withdrawal. <span><span class="ref-journal"><em>Am J Pscychiatry.</em> </span>1987;<span class="ref-vol">144</span>:205–208.</span> [<a href="/pubmed/3812789" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pscychiatry.&amp;title=Prevalence+of+tobacco+dependence+and+withdrawal.&amp;author=JR.+Hughes&amp;author=SW.+Gust&amp;author=TF.+Pechacek&amp;volume=144&amp;publication_year=1987&amp;pages=205-208&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref63">63. <span class="element-citation">American Psychiatric Association. <span><span class="ref-journal"><em>Diagnostic and Statistical Manual of Mental Disorders.</em> </span>3rd ed, revised. Washington, DC: American Psychiatric Association;<span class="ref-vol"> 1987</span></span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostic+and+Statistical+Manual+of+Mental+Disorders.&amp;title=American+Psychiatric+Association.&amp;volume=+1987&amp;publication_year=3rd+ed,+revised.+Washington,+DC:+American+Psychiatric+Association&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref64">64. <span class="element-citation">Stanton WR. DSM-III-R tobacco dependence and quitting during late adolescence. <span><span class="ref-journal"><em>Addict Behav.</em> </span>1995;<span class="ref-vol">20</span>:595–603.</span> [<a href="/pubmed/8712057" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Addict+Behav.&amp;title=DSM-III-R+tobacco+dependence+and+quitting+during+late+adolescence.&amp;author=WR.+Stanton&amp;volume=20&amp;publication_year=1995&amp;pages=595-603&amp;pmid=8712057&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref65">65. <span class="element-citation">World Health Organization. <span><span class="ref-journal"><em>The ICD-10 Classification of Mental and Behavioral Disorders. Clinical Descriptions and Diagnostic Guidelines. Geneva, Switzerland: World Health Organization;</em> </span>1992</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=The+ICD-10+Classification+of+Mental+and+Behavioral+Disorders.+Clinical+Descriptions+and+Diagnostic+Guidelines.+Geneva,+Switzerland:+World+Health+Organization;&amp;title=World+Health+Organization.&amp;publication_year=1992&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref66">66. <span class="element-citation">World Health Organization. <span><span class="ref-journal"><em>International Classification of Diseases. 9th Revision. Geneva, Switzerland: World Health Organization;</em> </span>1977:177–213.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=International+Classification+of+Diseases.+9th+Revision.+Geneva,+Switzerland:+World+Health+Organization;&amp;title=World+Health+Organization.&amp;publication_year=1977&amp;pages=177-213&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref67">67. <span class="element-citation">Hughes JR., Hlggins ST., Bickel WK. Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. <span><span class="ref-journal"><em>Addiction.</em> </span>1994;<span class="ref-vol">89</span>:1461–1470.</span> [<a href="/pubmed/7841857" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Addiction.&amp;title=Nicotine+withdrawal+versus+other+drug+withdrawal+syndromes:+similarities+and+dissimilarities.&amp;author=JR.+Hughes&amp;author=ST.+Hlggins&amp;author=WK.+Bickel&amp;volume=89&amp;publication_year=1994&amp;pages=1461-1470&amp;pmid=7841857&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref68">68. <span class="element-citation">Hughes JR. Why does smoking so often produce dependence? A somewhat different view. <span><span class="ref-journal"><em>Tobacco Control.</em> </span>2001;<span class="ref-vol">10</span>:62–64.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1763976/">PMC free article</a>]</span> [<a href="/pubmed/11226363" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Tobacco+Control.&amp;title=Why+does+smoking+so+often+produce+dependence?+A+somewhat+different+view.&amp;author=JR.+Hughes&amp;volume=10&amp;publication_year=2001&amp;pages=62-64&amp;pmid=11226363&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref69">69. <span class="element-citation">Smyth M., Browne F. <span><span class="ref-journal"><em>General Household Survey. London, UK: HMSO;</em> </span>1990</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=General+Household+Survey.+London,+UK:+HMSO;&amp;author=M.+Smyth&amp;author=F.+Browne&amp;publication_year=1990&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref70">70. <span class="element-citation">Henn&#x000ef;ngfield JE., Schuh LM., Jarvik ME. Pathophysiology of tobacco dependence. In: Bloom FE, Kupfer DJ, eds. <span><span class="ref-journal"><em>Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press;</em> </span>1995:1715–1729.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychopharmacology:+The+Fourth+Generation+of+Progress.+New+York,+NY:+Raven+Press;&amp;title=Pathophysiology+of+tobacco+dependence.+In:+Bloom+FE,+Kupfer+DJ,+eds.&amp;author=JE.+Henn&#x000ef;ngfield&amp;author=LM.+Schuh&amp;author=ME.+Jarvik&amp;publication_year=1995&amp;pages=1715-1729&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref71">71. <span class="element-citation">Nelson DE., Giovino GA., Emont SE., et al. Trends in cigarette smoking among US physicians and nurses. <span><span class="ref-journal"><em>JAMA.</em> </span>1994;<span class="ref-vol">271</span>:1273–1275.</span> [<a href="/pubmed/8151902" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=JAMA.&amp;title=Trends+in+cigarette+smoking+among+US+physicians+and+nurses.&amp;author=DE.+Nelson&amp;author=GA.+Giovino&amp;author=SE.+Emont&amp;author=+et+al.&amp;volume=271&amp;publication_year=1994&amp;pages=1273-1275&amp;pmid=8151902&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref72">72. <span class="element-citation">Silagy C., Lancaster T., Stead L., Mant D., Fowler G. <span><span class="ref-journal"><em>Nicotine Replacement Therapy for Smoking Cessation (Cochrane Review). The Cochrane Library. Oxford, UK: Update Software;</em> </span>2002;<span class="ref-vol">1</span></span> [<a href="/pubmed/12519537" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nicotine+Replacement+Therapy+for+Smoking+Cessation+(Cochrane+Review).+The+Cochrane+Library.+Oxford,+UK:+Update+Software;&amp;author=C.+Silagy&amp;author=T.+Lancaster&amp;author=L.+Stead&amp;author=D.+Mant&amp;author=G.+Fowler&amp;volume=1&amp;publication_year=2002&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref73">73. <span class="element-citation">Shifman S., Mason KM., Henn&#x000ef;ngfield JE. Tobacco dependence treatments: review and prospectus. <span><span class="ref-journal"><em>Annu Rev Public Health.</em> </span>1998;<span class="ref-vol">19</span>:335–358.</span> [<a href="/pubmed/9611623" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Public+Health.&amp;title=Tobacco+dependence+treatments:+review+and+prospectus.&amp;author=S.+Shifman&amp;author=KM.+Mason&amp;author=JE.+Henn&#x000ef;ngfield&amp;volume=19&amp;publication_year=1998&amp;pages=335-358&amp;pmid=9611623&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref74">74. <span class="element-citation">Report of the Surgeon General. <span><span class="ref-journal"><em>Nicotine Addiction. The Health Consequences of Smoking. Washington, DC: US Department of Health and Human Services;</em> </span>1988:210.</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nicotine+Addiction.+The+Health+Consequences+of+Smoking.+Washington,+DC:+US+Department+of+Health+and+Human+Services;&amp;title=Report+of+the+Surgeon+General.&amp;publication_year=1988&amp;pages=210&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref75">75. <span class="element-citation">Jorenby DE., Le&#x000ef;schow SJ., N&#x000ef;des MA., et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. <span><span class="ref-journal"><em>N Engl J Med.</em> </span>1999;<span class="ref-vol">340</span>:685–691.</span> [<a href="/pubmed/10053177" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med.&amp;title=A+controlled+trial+of+sustained-release+bupropion,+a+nicotine+patch,+or+both+for+smoking+cessation.&amp;author=DE.+Jorenby&amp;author=SJ.+Le&#x000ef;schow&amp;author=MA.+N&#x000ef;des&amp;author=al.+et&amp;volume=340&amp;publication_year=1999&amp;pages=685-691&amp;pmid=10053177&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref76">76. <span class="element-citation">Daly JW., Fredholm BB. Caffeine - an atypical drug of dependence. <span><span class="ref-journal"><em>Drug Alcohol Depend.</em> </span>1998;<span class="ref-vol">51</span>:199–206.</span> [<a href="/pubmed/9716941" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend.&amp;title=Caffeine+-+an+atypical+drug+of+dependence.&amp;author=JW.+Daly&amp;author=BB.+Fredholm&amp;volume=51&amp;publication_year=1998&amp;pages=199-206&amp;pmid=9716941&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref77">77. <span class="element-citation">Hughes JR., McHugh P., Holtzman S. Caffeine and schizophrenia. <span><span class="ref-journal"><em>Psychiatr Services.</em> </span>1998;<span class="ref-vol">49</span>:1415–1417.</span> [<a href="/pubmed/9826240" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Psychiatr+Services.&amp;title=Caffeine+and+schizophrenia.&amp;author=JR.+Hughes&amp;author=P.+McHugh&amp;author=S.+Holtzman&amp;volume=49&amp;publication_year=1998&amp;pages=1415-1417&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref78">78. <span class="element-citation">Kendler KS., Prescott CA. Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. <span><span class="ref-journal"><em>Am J Psych ia try.</em> </span>1999;<span class="ref-vol">156</span>:223–228.</span> [<a href="/pubmed/9989558" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Psych+ia+try.&amp;title=Caffeine+intake,+tolerance,+and+withdrawal+in+women:+a+population-based+twin+study.&amp;author=KS.+Kendler&amp;author=CA.+Prescott&amp;volume=156&amp;publication_year=1999&amp;pages=223-228&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref79">79. <span class="element-citation">Oberstar JV., Bernstein GA., Thuras PD. Caffeine use and dependence in adolescents: one-year follow-up. <span><span class="ref-journal"><em>J Child Adolesc Psychopharmacol.</em> </span>2002;<span class="ref-vol">12</span>:127–135.</span> [<a href="/pubmed/12188981" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Child+Adolesc+Psychopharmacol.&amp;title=Caffeine+use+and+dependence+in+adolescents:+one-year+follow-up.&amp;author=JV.+Oberstar&amp;author=GA.+Bernstein&amp;author=PD.+Thuras&amp;volume=12&amp;publication_year=2002&amp;pages=127-135&amp;pmid=12188981&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref80">80. <span class="element-citation">Hughes JR., Oliveto AH., Liguori A., Carpenter J., Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. <span><span class="ref-journal"><em>Drug Alcohol Depend.</em> </span>1998;<span class="ref-vol">52</span>:99–107.</span> [<a href="/pubmed/9800139" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Drug+Alcohol+Depend.&amp;title=Endorsement+of+DSM-IV+dependence+criteria+among+caffeine+users.&amp;author=JR.+Hughes&amp;author=AH.+Oliveto&amp;author=A.+Liguori&amp;author=J.+Carpenter&amp;author=T.+Howard&amp;volume=52&amp;publication_year=1998&amp;pages=99-107&amp;pmid=9800139&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref81">81. <span class="element-citation">American Psychiatric Association. <span><span class="ref-journal"><em>Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC: American Psychiatric Association;</em> </span>2000</span> <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Diagnostic+and+Statistical+Manual+of+Mental+Disorders.+4th+ed,+Text+Revision.+Washington,+DC:+American+Psychiatric+Association;&amp;title=American+Psychiatric+Association.&amp;publication_year=2000&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref82">82. <span class="element-citation">Lane JD., Phillips-Bute BG. Caffeine deprivation affects vigilance performance and mood. <span><span class="ref-journal"><em>Physiol Behav.</em> </span>1998;<span class="ref-vol">65</span>:171–175.</span> [<a href="/pubmed/9811379" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Physiol+Behav.&amp;title=Caffeine+deprivation+affects+vigilance+performance+and+mood.&amp;author=JD.+Lane&amp;author=BG.+Phillips-Bute&amp;volume=65&amp;publication_year=1998&amp;pages=171-175&amp;pmid=9811379&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref83">83. <span class="element-citation">Griffiths RR., Chausmer AL. Caffeine as a model drug of dependence: recent developments in understanding caffeine withdrawal, the caffeine dependence syndrome, and caffeine negative reinforcement. <span><span class="ref-journal"><em>Jpn J Neuropsychopharmacol.</em> </span>2000;<span class="ref-vol">20</span>:223–231.</span> [<a href="/pubmed/11326548" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Jpn+J+Neuropsychopharmacol.&amp;title=Caffeine+as+a+model+drug+of+dependence:+recent+developments+in+understanding+caffeine+withdrawal,+the+caffeine+dependence+syndrome,+and+caffeine+negative+reinforcement.&amp;author=RR.+Griffiths&amp;author=AL.+Chausmer&amp;volume=20&amp;publication_year=2000&amp;pages=223-231&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="ref84">84. <span class="element-citation">Greenberg JL., Lewis SE., Dodd DK. Overlapping addictions and selfesteem among college men and women. <span><span class="ref-journal"><em>Addict Behav.</em> </span>1999;<span class="ref-vol">24</span>:565–571.</span> [<a href="/pubmed/10466852" target="pmc_ext" ref="reftype=pubmed&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Addict+Behav.&amp;title=Overlapping+addictions+and+selfesteem+among+college+men+and+women.&amp;author=JL.+Greenberg&amp;author=SE.+Lewis&amp;author=DK.+Dodd&amp;volume=24&amp;publication_year=1999&amp;pages=565-571&amp;pmid=10466852&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=3181622&amp;issue-id=200428&amp;journal-id=1550&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Dialogues in Clinical Neuroscience</span> are provided here courtesy of <strong>Les Laboratoires Servier</strong></div></div>
            
            
        
            
        </div>
        <!-- Book content -->
    </div>
    
    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            
        </div>
        
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC3181622/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC3181622/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC3181622/pdf/DialoguesClinNeurosci-5-175.pdf">PDF (200K)</a></li> | <li><a href="#" data-citationid="PMC3181622" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3181622%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />
                             Facebook
                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3181622%2F&amp;text=Alcohol%2C%20nicotine%2C%20caffeine%2C%20and%20mental%20disorders"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />
                             Twitter
                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3181622%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />
                             Google+
                        </a></li></ul></div>
        
        <div id="ajax-portlets" data-pmid="22033899" data-aiid="3181622" data-aid="3181622" data-iid="200428" data-domainid="1550" data-domain="diaclinneuro" data-accid="PMC3181622" data-md5="780867c8a3faa44316ece49e7c045501"></div>
                
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script>
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>



<div id="body-link-poppers"></div>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-06-11T21:18:47-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=portal105&amp;ncbi_phid=CE8C0C85D004A13100000000047E0259&amp;ncbi_session=CE8C0C85D0052F71_1150SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3181622%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=diaclinneuro&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC3181622/&amp;ncbi_app=pmc" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C0C85D0052F71_1150SID /projects/PMC/PMCViewer@4.46 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>
</html>